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 Human embryonic stem (hES) cells are now a central platform in the fields of 
developmental biology and regenerative medicine. Prcise control of stem cell fate is a 
fundamental issue in the use of hES cells in the context of cell therapy. Human ES cells 
are exquisitely sensitive to microenvironmental cues, making control of the environment 
an important step in controlling cell fate. We examined three ways in which the 
microenvironment can be controlled to alter hES cell b havior. 
 We first examined the effects of polydimethylsiloxane (PDMS) growth surfaces 
on hES cell survival and maintenance of pluripotency. PDMS is an important material in 
the fabrication of microdevices that can be used to provide precise microenvironmental 
control. Lightly cured, untreated PDMS was shown to be a highly variable and poor 
growth surface for hES cells. Some of the adverse effects caused by PDMS could be 
mitigated with increased curing or UV treatment of he surface. However, neither 
modification provided a growth surface that supported pluripotent hES cells as well as 
polystyrene, making it evident that more work is need d before growth in PDMS 
microdevices is equivalent to growth on traditional cell culture plates. This work provides 
a basis for further optimizing the functionalization f PDMS for hES cell culture, moving 
towards the use of microdevices in establishing precise control over stem cell fate. 
 The second study explored the use of an easily constructed diffusion-based device 
to grow hES cells in culture on a defined, physiologic oxygen (O2) gradient. The results 
we obtained were consistent with those in the literature. We observed greater hES cell 
survival and higher levels of pluripotency markers in the lower oxygen regions of the 
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gradient. The greatest benefit was observed at O2 levels below 5%, narrowing the 
potential optimal range of O2 for the maintenance of pluripotent hES cells.  
 Finally, we developed a completely adherent, feeder-fre  neural differentiation 
protocol using small molecules and common medium supplements for in vitro 
differentiation of both neural precursors and neurons from human pluripotent cells. This 
protocol greatly reduces the cost and time scale needed to obtain electrophysiologically 
functional neurons in culture as compared to other reported protocols. Neural precursors 
were obtained with high efficiency and transplanted into a murine model of focal 
ischemic stroke. In vivo, hES cell-derived neural precursors survived, improved 
neurogenesis, and differentiated into neurons. Transpl t also led to a more consistent 
and measurable sensory recovery after stroke as compared to untransplanted controls. 
This protocol represents a potentially translatable method for the generation of CNS 
progenitors from human pluripotent stem cells. 
 The results of this work demonstrate the importance of controlling the 
microenvironment when seeking to control hES cell fate and provide insight into the best 
conditions for both maintenance of pluripotency andneural differentiation in 











 Human embryonic stem (hES) and induced pluripotent stem (hiPS) cells are of 
great interest in the fields of developmental and cancer biology and are central to the new 
field of regenerative medicine. Both cell types are pluripotent, meaning they exhibit the 
ability to differentiate into cell types from all three embryonic germ layers. Under the 
right conditions, pluripotent stem cells can be induced to differentiate into any cell type, 
providing an unmatched window into human embryonic development. Human ES and 
hiPS cells can be used to study the processes of cell fate specification and the pathologies 
that can disrupt them. In addition, these cell types are of interest in cancer biology 
because of their similarities to cancer cells, including self-renewal and differentiation 
potential. Embryonic stem cells are particularly similar to embryonal carcinoma (EC) 
cells which are seen as the malignant counterparts to ES cells. Human ES cells that are 
not carefully maintained and screened can undergo karyotypic changes that closely 
mimic the mutations found in EC cells and can lose much of their ability to 
differentiate.1-3 In fact, a definitive method of maintaining a normal karyotype during 
extensive passaging of hES cells has not yet been identified. Finally, the proliferative 
potential of hES cells makes them an important source for the large numbers of cells 
required for anticipated cell therapies. A large master bank of undifferentiated cells that 
can then be driven down a specific lineage offers both the potential for replacement of 
 
 2
damaged cells and tissues and the ability to gain a gre ter understanding of differentiated 
cells that could inform therapies focusing on endogenous repair.   
 Control over hES cells in the context of their usein cell therapies is the central 
issue in translational stem cell biology. The major unifying feature of work in this thesis 
is a focus on various methods to control the fate of pluripotent stem cells. In this context, 
pluripotency is a double-edged sword. The ability of pluripotent cells to form a myriad of 
cell types makes hES cells an ideal source material, but controlling one pathway of 
differentiation over another is technically difficult. Achieving purity of the final cell 
therapy by excluding undifferentiated cells is also difficult. Until recently, no good 
method was available to sort undifferentiated cells out of a mixed population. 
 Transplantation of pluripotent cells as part of a cell graft can lead to teratoma 
formation,4 since teratomas are the natural default of uncontrolled differentiation of hES 
cells. This is the reason teratoma assays are used to monitor pluripotency of hES and 
hiPS cells. Human ES cells that have undergone karyotypic changes during culture also 
may develop into teratocarcinomas.1 Genetic and epigenetic changes that would not be 
discovered in routine karyotyping5, 6 and incomplete reprogramming in hiPS cells7, 8 can 
also result in subpopulations of cells that remain relatively undifferentiated, leading to 
pluripotent contamination in a cell graft and possible teratoma formation. In addition, 
incomplete derivation of the desired cell type may allow for subpopulations that have not 
differentiated or have differentiated into cell types that can reduce or counteract the 
desired therapeutic effect of cell transplantation. There is thus a great deal of interest in 
optimizing the control of human pluripotent stem cells in culture, both during 
maintenance of self-renewing cultures and differentiation into desired cell types.  
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 Human ES cells are traditionally derived from the inner cell mass (ICM) of the 
blastocyst, a pre-implantation embryo. If the blastocyst were implanted, the cells of the 
ICM would develop into the fetus, while the outer trophoblast layer of cells would 
contribute to the placenta. Derivation of hES cells was first reported in 1998, from 
discarded embryos that were created for in vitro fetilization (IVF), but were no longer 
needed.9 There have also been reports of hES cell lines derived from pre-blastocyst 
embryos10 or single blastomeres.11 Advanced Cell Technology has begun a Phase I 
clinical trial using retinal pigment epithelial cells (RPE) derived from a single blastomere 
hES cell line.12 However, derivation from the blastocyst stage is still more standard, 
likely increasing both derivation efficiency10, 14 and cell line quality.15 
 More recently, methods have been elucidated to reprogram somatic cells to induce 
pluripotency. The basis of reprogramming is the introduction of multiple genes expressed 
by embryonic stem cells, but lost with differentiation. Introduction of these genes results 
in epigenetic reorganization of expression patterns that restore pluripotency. Since the 
first derivation of hiPS cells in 2007,16 a huge number of somatic cell types and 
reprogramming strategies have been employed to create c ll lines.17 Induced pluripotent 
lines have been derived from dermal skin fibroblasts,16, 18 adipose tissue,19 peripheral 
blood cells,20-22 and multiple other cell types. Fewer reprogramming factors are requierd 
if hiPS cells are derived from a stem cell source.23 Additionally, a growing number of 
hiPS cell lines have been created from patients with a number of diseases, including type 
1 diabetes,24 Parkinson's and Huntington's diseases,25 and amyotrophic lateral sclerosis.26 
These disease-specific lines can serve as a platform for drug screening and have already 
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produced insights into pathogenesis of disease that would not have been possible without 
hiPS cells. 
 Concerns over mutagenesis as a consequence of randm retroviral integration into 
the genome and lack of control over expression of ex g nous genes used in 
reprogramming have led to a number of modifications a d innovations for derivation of 
hiPS cells. c-Myc has been of particular concern as a reprogramming factor since it is an 
oncogene.27 In order to minimize these issues, transgene-free iPS cells have been 
created28-33 and some protocols have found ways to induce pluripotency without the use 
of c-myc.34-36 More recently, small molecules have been used to reduce the number of 
exogenous pluripotency factors needed to reprogram so atic cells.37 
 The drive toward clinical application of stem cells has been the impetus for 
developing reagents and methods that can be safely us d in humans. Human ES cell lines 
were first cultured as colonies on a trophic layer of mouse embryonic fibroblasts (MEFs) 
in medium containing serum (or serum replacement) and basic fibroblast growth factor 
(bFGF) and this method is still in widespread use.38 A number of other culture conditions 
have been tested, including the use of human feeder cells39, 40 or feeder-free cultures 
using conditioned41, 42 or defined43-46 media. There is increasing interest in passaging as 
single cells, rather than colonies, as such cultures a  easier to scale up for therapeutic use 
without the inherent heterogeneities that result from hand-passaging. Colonies have 
successfully been dissociated and passaged as single cells using a number of enzymes, 
including accutase,47, 48 TrypLE Express,40, 49 and cell dissociation buffer.50  
 Xeno-free conditions are also under examination, as the removal of animal 
products is widely viewed as necessary for large-scale linical use.51 The use of human 
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feeder cells with defined medium is possible,40 but many are beginning to focus on the 
use of human or synthetic surfaces that may replace Matrigel, a complex and variable 
extracellular matrix (ECM) derived from a mouse tumor52 that is commonly used to 
support hES cell growth in research labs. Human plasma-derived vitronectin53 and 
recombinant human laminin isoforms54, 55 have been shown to support hES cell growth. 
Plasma-etched tissue culture polystyrene was able to support pluripotent stem cell growth 
without first coating with ECM, but proteins from MEF-conditioned medium (MEF-CM) 
likely adsorbed on the surface and contributed to hES cell adhesion.56 Klim et al.57 found 
that self-assembled monolayers (SAMs) presenting heparin-binding motifs were able to 
support the growth of human pluripotent stem cells. Isolated ECM-based peptides may 
also be viable growth surfaces.58, 59 Other groups are working on fully synthetic polymers 
that allow for long-term growth of pluripotent stem cells.60-62 
 Proper culture conditions for the maintenance of healt y pluripotent stem cells are 
needed to manufacture sufficient numbers of cells for cell therapy that have defined 
phenotype and expression patterns, as measured by clear purity and potency criteria. A 
common feature of the methods discussed above and those discussed in this thesis is to 
mimic parts of the normal embryonic environment, capturing essential features of that 
environment for use in controlling cell fate. Most directed differentiation protocols 
developed for clinical applications are based on developmental biology. 
 One aspect of the normal developmental environment is growth in three 
dimensions (3D), rather than an artificial 2-dimensio al (2D) monolayer. Current 
protocols to differentiate a variety of cell types often involve suspension culture of 3-
dimensional aggregates known as as embryoid bodies (EB ).63 EBs can be formed by 
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using the hanging drop method,64 suspension culture in low attachment cell culture 
dishes,65, 66 or by forced aggregation.67-70 Forced aggregation methods were designed, in 
part, to try and reduce heterogeneity in the starting size of EBs, an effect that also be 
achieved through the use of rotary culture.71 Once formed, EBs are grown in suspension 
and growth factors added to the medium are differentially encountered by cells as a 
function of position within the EB. Those cells on the inside of the aggregate will be 
exposed to lower concentrations of medium components as a function of diffusion and 
consumption by the outer cells. This heterogeneity ma be mitigated by the incorporation 
of microparticles containing biologically active molecules.72, 73  
 When 3D mechanical factors do not seem to be a necessity in differentiation, 
analysis and the control of culture conditions can be less complicated in adherent culture 
systems. Adherent culture allows for precise control of the ECM presented to the cells 
and all cells should be exposed to the same concentrations of bioactive molecules in the 
culture medium. Large scale cultures can be achieved using multilayer cell culture flasks 
after a differentiation protocol has been determined. 
 This thesis project explored three ways in which the microenvironment of hES 
cells can be controlled to alter their behavior. In order to facilitate future studies to 
improve culture conditions in MEMS or microfluidics devices, we investigated ways in 
which the processing of PDMS can affect the maintenance of ES cells. We then explored 
the use of a diffusion-based oxygen (O2) gradient to investigate the effects of O2 tension 
on hES cell proliferation and pluripotency to provide further improvement in hES cell 
culture conditions. Finally, we explored the use of small molecules and common medium 
supplements in the adherent and feeder-free differentiation of hES-derived neural 
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precursors that were then used for cell therapy in a murine model of stroke. We identified 
a differentiation protocol that reduces the expense and time necessary to generate 
functional neurons from hES cells. 
 
Specific Aim 1: Improvement of Human Embryonic Stem Cell Growth on 
Polydimethylsiloxane 
 
 Because the environment is so important in determining behavior of hES cells, 
control over the local cellular microenvironment is a critical part of optimizing hES cell 
culture. This control is achievable using micro-electrico-mechanical systems (MEMS) 
and microfluidics devices.74, 75 These structures can be used to examine three-
dimensional culture conditions,76, 77 exert quantifiable mechanical forces such as stretch78 
or fluid shear stress,77 and present gradients of various active molecules.79 Precise control 
of growth surface topography80, 81 is also possible. Polydimethylsiloxane (PDMS) is a
commonly chosen material in the fabrication of these devices for a number of reasons, 
including optical transparency, lack of autofluoresc nce, and low cost. However, PDMS 
can have a variety of negative effects on cells grown in microdevicces. These effects and 
the methods used to mitigate them are cell-type specific and there are no reports in the 
literature specifically examining the growth of hES cells on PDMS surfaces. 
 We hypothesized that two factors: the (i) level of p lymerization and (ii) surface 
chemistry, manipulated by altering curing conditions and post-curing treatments, would 
affect use of PDMS as a growth surface for hES cells. We tested this hypothesis by 
modulating the timing and temperature at which the PDMS was cured and using it either 
untreated or treated with ultraviolet (UV) radiation. Small polymer chains and monomers 
left within the bulk polymer can diffuse into the culture area and PDMS can pull 
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hydrophobic molecules out of the medium.82, 83 Both of these effects could negatively 
impact cell growth and may be ameliorated by more cmplete curing. Additionally, 
PDMS is a very hydrophobic surface and treatments such as UV can make the surface 
somewhat more hydrophilic,84, 85 possibly improving the adsorption of ECM and cell 
adhesion. Atomic force microscopy (AFM) was used to examine the roughness of the 
growth surfaces. PDMS surfaces were coated with Matrigel and seeded with hES cells, 
which were cultured for 2-5 days before fixation. We used staining for octomer-binding 
transcription factor 4 (OCT4) as a measure of pluriotency and terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining as a measure of 
cell death as a function of the PDMS treatments. 
 
 
Specific Aim 2: Examine the Effect of Oxygen Gradients on Human Embryonic Stem 
Cell Maintenance Using a Diffusion-Based Device 
 
 The level of O2 in culture is increasingly recognized as an important factor in 
controlling cell behavior and fate. Typical mammalian tissues range from 2-9% O2,
86 
while most cell culture is carried out at ~20%. Growing various cell types at O2 tensions 
in lower, more physiologic ranges (often referred to as "hypoxia" in the literature) is 
generally beneficial as compared to traditional cell ulture O2 levels.  
 Lowered O2 can be a factor in both maintaining a differentiated phenotype
87-92 
and in directed differentiation of various cell types93-98 in culture. In other cases, 
physiologic O2 tension improves the maintenance of undifferentiated stem cell 
populations,99, 100 including hES cells.101-104 Resident stem cell populations often reside in 
low O2 niches within a given tissue, perhaps to avoid incurring too much oxidative 
damage over time.86  
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 Reports of lowered O2 in cell culture conditions employ highly variable 
conditions and are usually compared to traditional cell culture, rather than within 
physiologic ranges. It is thus difficult to directly compare the O2 tensions used across 
multiple studies. Interpretation of these results is further complicated by variable 
reperfusion events where cells are exposed to room air during passaging and feeding. Cell 
culture conditions for the maintenance of hES cells should avoid oxidative damage that 
may limit proliferation and contribute to DNA damage and culture adaptation, in which 
cells that have sustained DNA damage or epigenetic changes overtake cell culture and 
replace healthy cells. It is also important that O2 levels are not lowered to the extent that 
they negatively impact cell survival. 
 We used a relatively simple, diffusion-based devic to examine the maintenance 
of healthy, undifferentiated hES cells exposed to an O2 gradient over the course of 24 and 
60 hours of culture. This device provided O2 levels spanning the bulk of the phsyiologic 
range, allowing for a comparison of multiple O2 conditions within the same culture. We 
hypothesized that lowered O2 levels that more closely mimic physiologic conditions 
would increase cell growth and better maintain pluri otency in hES cells. These end-
points were tested using immunocytochemical staining for 4',6-diamidino-2-phenylindole 
(DAPI) to label all cell nuclei and the pluripotency markers OCT4 and nanog. TUNEL 
staining was used to examine cell death and bromodeoxyuridine (BrdU) incorporation 
was used to examine proliferation. Estimated O2 levels were determined using 





Specific Aim 3: Develop a Feeder-Free and Fully Adherent Protocol for Neural 
Differentiation of Human Pluripotent Cells for Therapeutic Use 
 
 Many protocols have been devised to develop neural precursors and, ultimately, 
neurons from hES and hiPS cells. However, most suchprotocols are problematic for 
therapeutic use. Suspension culture and co-culture with feeder cells can introduce 
heterogeneities, making consistent differentiation difficult to achieve and complicating 
analysis. Many protocols employ expensive recombinant factors for both neural precursor 
induction and the derivation of terminally differentiated neurons. These are long-term 
cultures and the need for expensive medium additives l mits the scale of experiments. 
Scale-up for therapeutic use will be particularly difficult in such systems, as very large 
volumes of these factors will be necessary. Small mo ecules and feeder-free, adherent 
cultures have recently been developed for mitigation of some of these problems.  
 Neural precursors are generally the cell of interest in cell replacement therapies 
for neurological disorders. However, it is important to establish the ability of neural 
precursor cells derived for this purpose to further differentiate into terminally 
differentiated neurons. Most studies have relied on ide tifying immunohistochemical 
markers to confirm neuronal differentiation, but electrophysiological properties are also 
extremely important. Cells may express differentiated markers without forming the 
receptors and channels necessary in neuronal function. I  is thus not always clear that 
neural precursors derived from various protocols can become fully functional neurons in 
vitro or in vivo. The ability to derive neurons in vitro is not a guarantee that hES-derived 
neural precursor cells will differentiate similarly in the disease environment after 




 We developed a feeder-free and fully adherent protocol to differentiate neural 
precursors and functional neurons from hES and hiPScells. This protocol uses small 
molecules for neural induction and eschews the recombinant factors most often used in 
the differentiation of neurons. The efficiency of neural induction was tested using nestin 
(a general marker of neural precursors) and paired box gene 6 (PAX6) and (sex 
determining region Y)-box 1 (SOX1), both markers of forebrain differentiation. Neurons 
were identified using staining for neuronal nuclei (NeuN) and neurofilament L (NF). 
They were further characterized using western blotting for various subunits of neuronal 
receptors. Electrophysiological function was examined using whole-cell patch clamp 
recording.  
 Cells at the neural precursor stage were transplanted i to the penumbra in a 
murine focal ischemic stroke model. We hypothesized that the transplanted cells would 
differentiate into neurons, increase behavioral recov ry, and enhance endogenous 
neurogenesis. Animals were tested for behavioral recov ry using the adhesive removal 
test.106 Tissue sections within the stroke region were colle ted 28 days after transplant 
and stained for BrdU incorporation as a marker of pr liferation, NeuN as a marker of 
neurons, and Collagen IV (Col IV) as a marker of blod vessels. Transplanted cells were 
identified using a Hoechst label that was applied bfore transplantation. 
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CHAPTER 2: Processing of Polydimethysiloxane Surfaces is an Important Factor in 





 Polydimethylsiloxane (PDMS) has increasingly been used in biological studies, 
particularly in microelectromechanical systems (MEMS) and microfluidics. PDMS is 
desirable for both rapid prototyping and long-term designs because it is inexpensive, 
relatively easy to fabricate and mold, and durable. The material is optically transparent in 
frequencies as low as 230 nm and does not fluoresce, fa ilitating imaging within a 
device.107 Low conductivity84 and permeability to gases108, 109 are other features that make 
this polymer a common choice for the fabrication of micro-devices. It has been used in a 
variety of applications, including immunoassays,110-112 in situ hybridization,113, 114 and 
cell sorting.115-117 It has also been used to fabricate devices used to control the 
microenvironment of cultured cells in a myriad of ways.74, 118  
 A number of MEMs and microfluidics devices have ben created to provide 
chemical gradients in cell culture, and many incorporate PDMS.119 One such device 
provides a defined static gradient of bioactive molecu es without introducing cells to 
flow, and this device does incorporate a PDMS cell culture surface.79 The gas 
permeability of PDMS lends itself to use in creating gas gradients as well. Dissolved 
gases diffuse readily through PDMS membranes, allowing gases such as O2 to either be 
added to culture or pulled out of it by reactions carried out in chambers separated from 
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cell culture by PDMS.120-122 The geography of these devices can then be manipulted to 
create the desired gradient.   
 PDMS can also be molded into a variety of shapes to examine the effects of 
microtopography on cell response. The addition of gr oves123 or posts124 on the cell 
culture surface has been shown to alter fibroblast and connective tissue progenitor cell 
behavior, respectively. Both textures affected cellgrowth and alignment, with responses 
varying based on the size of the incorporated textur . Microtexture has also been used to 
affect the differentiation of mouse ES cells. Growth on textured surfaces reduces 
proliferation by increasing tension on stress fibers, but also increases the consistency of 
beating patterns in mouse ES (mES)-derived cardiomyocytes.125 Posts on the growth 
surface can also increase the generation of neuronal cells from mES-derived neural 
precursors.81 
 Most mammalian cells require attachment to survive and proliferate, and human 
embryonic stem (hES) cells are no exception. Many microdevices use known 
biocompatible materials as the attachment substrate, adding PDMS microchannels over 
the culture surface. Direct interaction of cells with PDMS is not a concern in these 
devices, but material concerns may still affect cell growth due to the leaching of low 
molecular weight species (LMWS) into the medium andthe partitioning of hydrophobic 
signaling molecules from the medium into the bulk polymer.82, 83 Paguirigan and Beebe82 
found that increasing the ratio of the PDMS surface rea to the overall volume (SA/V) of 
culture negatively impacted the proliferation of mouse mammary fibroblasts (MMFs). 
Increased SA/V appeared to cause cell cycle arrest of many cells in the S/G2 phases, 
indicating a possible defect in cell division. Additionally, MMFs demonstrated increased 
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glucose consumption with increasing surface area of the PDMS when volume was 
constant. The exact mechanisms driving these negative effects were unclear, but LMWS 
leaching into the culture medium and hydrophobic molecule partitioning out of it were 
both suspects.  
 Regehr et al.83 carried out a study with human breast cancer (MCF-7) cells and 
demonstrated both LMWS leaching and hydrophobic signal partitioning. Even after 
extraction of the PDMS surfaces with ethanol, LMWS ranging from below 20 to over 90 
monomers were detectable in water incubated within a PDMS microchannel for 24 hours. 
A silicon signal indicating PDMS accumulation was detectable in the membranes of 
MCF-7 cells after 24 hr incubation in the microchannel and cell response to estrogen (a 
hydrophobic steroid) was reduced as compared to controls without PDMS. Even in the 
absence of cells, PDMS microchannels could reduce the strogen concentration in the 
medium by an order of magnitude. It is not yet clear whether the presence of PDMS in 
the cell membrane has direct negative effects on cells, but the removal of signaling 
molecules from culture medium can undeniably affect c ll response. 
 Some devices, including many that incorporate microtexture, do rely on PDMS as 
a growth surface,79, 81, 120, 123-128 which makes it important to ensure that cells can readily 
attach. However, PDMS is a very hydrophobic surface in an unmodified state, causing 
poor cell attachment and introducing toxicity to some cell types.129 Hydrophobic surfaces 
have been shown to alter the conformation of extracellular matrix (ECM) molecules such 
as fibronectin, reducing the availability of integrin attachment sites for various cell 
types.130-133 These changes can affect cell adhesion, proliferation, and differentiation. 
However, even with possible conformational changes, coating with ECM can reverse low 
 
 15
attachment and cell death in some cell types.129 In our experiments, we found that naked 
PDMS was a very poor growth surface for hES cells, causing extremely high levels of 
cell death even in mouse embryonic fibroblast conditioned medium (MEF-CM), which 
should have a number of extracellular matrix (ECM) molecules in solution that could 
adsorb onto the surface.  
 The surface of PDMS can be treated to render it more hydrophilic or hydrophobic 
in order to affect cell attachment and growth. Increasing hydrophilicity can improve 
outcomes,134, 135 while increasing hydrophobicity is expected to decrease cell attachment 
and survival.135 Treatments that increase hydrophilicity include plasma,85 
ultraviolet/ozone (UVO),84, 85, 136 and ultraviolet radiation (UV).84, 85 All three can alter 
the chemical composition at or near the surface of the polymer by removing -CHx groups 
and increasing the number of hydroxyl (-OH) groups. Other effects of these treatments 
may include further cross-linking, chain scission, a d smoothing at the surface. Cross-
linking density in the polymer can affect cell growth on PDMS surfaces.137 This response 
may be cell-type specific and may be a function of reduced LMWS leaching from the 
bulk PDMS or hydrophobic molecule partitioning into it. UV treatment is a slower 
process than plasma or UVO and increases the number of -OH groups on the surface to a 
lesser degree,84 but may achieve deeper penetration of the bulk polymer without cracking 
the surface.136  
 Increasing the hydrophilicity of the surface without saturating it with -OH groups 
may be desirable for cell attachment. Self-assembling monloayers (SAMs) presenting 
hydroxyl groups reduced the attachment of αv integrins to fibronectin as compared to 
other hydrophilic surfaces.133 In a study of collagen IV-coated ethyl acrylate surfaces 
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with varying levels of -OH present at the surface, maximal growth of human umbilical 
endothelial cells was observed at both saturation and relatively low levels, while surfaces 
with intermediate levels of -OH or devoid of it did not support these cells as well.138 The 
optimal levels of -OH were then altered when laminin coating was added, further 
suggesting the need for application-specific optimization of hydrophilicity. 
 Response to culture on PDMS treated in various ways is cell-type specific, 
suggesting that the properties of a PDMS growth surface will need to be optimized for 
the particular cell type used.139 ES cells are exquisitely sensitive to the microenvironment 
and are thus prime candidates for control using microdevices. However, the interaction of 
these cells with PDMS has not been the subject of much investigation. Multiple PDMS 
constructs have been designed to control the size and shape of ES cell colonies or 
embryoid bodies,70, 140-143 but these do not require adherent growth of the cells on PDMS 
surfaces. Murine ES cells have also been grown in a PDMS-based microfluidics system 
and exposed to varying flow rates,144 but the growth surface itself was not PDMS. A few 
studies have examined the growth of mES cells or thei derivatives on PDMS surfaces. 
Liu et al.145 reported a growth deficiency and reduced neural differentiation when mES 
cells were grown on a mouse embryonic fibroblast (MEF) feeder layer seeded on PDMS. 
However, Migliorini et al.81 found that mES cell-derived neural precursors had better 
survival on polyornithine/fibronectin coated PDMS than on similarly coated glass 
surfaces. These studies further demonstrate the need for cell type- and application-
specific methods to functionalize PDMS as a growth surface. 
 We examined the growth of hES cells on PDMS surfaces. Traditional hES cell 
culture is carried out on a MEF feeder layer, but inclusion of MEFs can complicate 
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analysis, particularly since PDMS can also affect the adhesion of MEFs.145 We thus 
chose to examine the effects of PDMS in feeder-free hES cell culture. Both the curing 
conditions and the surface treatment of PDMS surfaces were varied in an attempt to 
increase cell survival and pluripotency. We show that incomplete curing conditions can 
decrease cell viability and pluripotency, but that UV treatment largely reverses these 
effects. To our knowledge, this is the first report of hES cells grown in feeder-free, 





2.2.1: PDMS Fabrication 
 PDMS (Sylgard 184, Dow Corning, Midland, MI) was spun 10 µm thick on a 
borosilicate glass wafer and cured before a polystyrene wall (9x7 mm2) was attached 
using room temperature vulcanizing (RTV) silicone sealant (Dow Corning) in order to 
contain medium in the cell culture area. PDMS was either lightly cured (110oC for 15 
minutes) or subjected to longer, higher temperature c ing conditions (150oC for 3 
hours). These conditions were chosen based on protocols used within two separate labs 
regularly working with PDMS structures. In some cases, chips were treated with UV at 
365 nm overnight or treated in an air plasma machine at maximum frequency for 2 
minutes. Tissue culture polystyrene coated with Matrigel, known to support hES cell 
growth, was used as a control surface. 
 
2.2.2: Human ES Cell Culture 
 H1 hES cells (p35-50, WiCell Madison, WI) were maint ned on a MEF feeder 
layer in a standard growth medium (DMEM/F12, 20% KSR, 1% L-glutamine, 1% 
NEAA, 4 ng/ml bFGF, 55 µm β-ME; Invitrogen, Carlsbad, CA) in an incubator 
maintained at 37oC, 5% CO2, and 3% O2. For PDMS experiments, cells were treated with 
1.5 mg/ml collagenase type IV (Sigma-Aldrich, St. Louis, MO) in DMEM/F12 for 15-30 
minutes, then scraped off the plate in culture medium. MEFs were removed from the 
suspension by allowing the colonies to settle to the bottom of a tube in several successive 
washes. Cell colonies were then treated with accutase (Invitrogen) to break them into a 
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single-cell suspension. This suspension was plated at 60,000-80,000 cells/cm2 on PDMS 
or tissue culture treated polystyrene control surfaces that were pre-coated with growth 
factor-reduced Matrigel (BD Biosciences, Sparks, MD) diluted at a 1:30 ratio in 
DMEM/F12. Cells were grown in MEF-CM supplemented with 100 ng/ml basic 
fibroblast growth factor (bFGF, R&D Systems, Minneapolis, MN). MEF-CM was created 
by growing MEFs in standard hES cell medium for 24 hours and then filtering before use. 
Medium was changed at least once every two days. 
 
2.2.3: Immunocytochemistry for OCT4 and TUNEL 
 At 2 or 5 days of growth, cells were fixed in 4% paraformaldehyde (PFA) and 
subjected to OCT4 and TUNEL double staining. TUNEL staining was carried out using 
the kit vendor instructions (DeadEnd™ Fluorometric TUNEL System, Promega 
Corporation, Madison, WI). Blocking was carried outwi h 10% normal donkey serum 
(NDS) in phosphate buffered saline (PBS) and an OCT3/4 antibody (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) was applied overnight at 4oC at a 1:100 dilution in 
5% NDS. An Alexafluor-conjugated secondary antibody (Invitrogen) was applied for 1 
hour at room temperature (RT) in 1% NDS. Vectashield with DAPI (Vector Labs, 
Burlingame, CA) was diluted 1:10 in PBS and used to counterstain nuclei.  
 Cells were imaged with fluorescent microscopy in PBS to avoid removal of the 
walls of the culture wells, which may have pulled cells off of the surface. Double staining 
of DAPI with OCT3/4 or TUNEL was quantified using Adobe Photoshop (Adobe 
Systems Incorporated, San Jose, CA) or ImageJ. Data are presented as mean ± SEM. 
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However, large variation between cultures and small sample sizes made comparisons of 





2.3.1: UV Treatment and Increased Curing Conditions Improve hES Cell Yield and 
Maintenance of Pluripotency at Two Days on PDMS 
 
 In early experiments in which hES cells were seeded onto naked PDMS surfaces, 
we observed a cell death rate of greater than 80% and very few cells retained 
pluripotency (data not shown). We thus carried out further experiments with Matrigel-
coated surfaces. Cells grew as colonies of OCT4-positive cells surrounded by hES cells 
that have lost OCT4 expression and possible occasion l c ntamination with MEFs which 
may be identifiable by their substantially larger nuclei (Figure 2.1).  
 We quantified the total number of cells, hES cell o ony sizes (morphologically 
determined by OCT4 staining), the total percentage of OCT4, and the total percentage of 
TUNEL staining on each surface. The same surface area was observed for each PDMS 
treatment. Colony sizes at 2 days ranged from less than 5 cells to slightly over 200. The 
smallest numbers of colonies and total OCT4-positive cells were observed on the lightly 
cured, untreated surfaces (Table 2.1). Both measures increased when surfaces were either 
treated with UV or subjected to increased curing conditions. Interestingly, surfaces 
subjected to both treatments were more similar in these measures to the lightly cured, 
untreated surfaces. The average colony size (pooled data, Table 2.1) and the size 








FIGURE 2.1: Representative hES Cell Growth on PDMS Surfaces at Two Days 
DAPI (blue, cell nuclei), OCT4 (red, pluripotency), and TUNEL (green, cell death) 
staining of cells at each condition. Cells grew as OCT4+ colonies surrounded by 
differentiated cells. Larger percentages of cell death were observed on lightly cured, 
untreated PDMS. These surfaces also exhibited lower lev ls of OCT4 staining. 
 
 
TABLE 2.1: UV Treatment and Increased Curing Increased the Numbers of 
Colonies and OCT4-Positive Cells at Two Days on PDMS 
 
Condition # Colonies  OCT4+ Cells Average Colony Size 
Light curing, untreated 258 4534 19 
Light curing, UV 435 9029 22 
Increased curing, untreated 375 8275 23 
Increased curing, UV 364 5355 15 
 
Pooled data from two experiments are shown. A lower number of colonies and OCT4-
positive cells were found on the lightly cured, untrea ed surfaces, but no difference in 
average colony size was observed. 
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FIGURE 2.2: Human ES Cell Colony Size Distribution on PDMS was not 
Affected by Increased Curing or UV Treatment at Two Days 
Data shown are pooled from two experiments. Two days after seeding, colony sizes 
ranged from under 5 to just over 200 cells, with most at or below 25 cells. Data points 
represent the percentage of quantified colonies at or below the plotted size. Larger 
numbers of colonies of all sizes were found on the increased curing conditions and UV-
treated surfaces vs. lightly cured, untreated PDMS surfaces, but neither treatment 
affected the percentage distribution of colony size. LC = lightly cured, IC = increased 





 The lowest percentage of OCT4-positive cells at two days (43.6 ± 8.4%) was 
observed on the lightly cured, untreated PDMS. This percentage was significantly 
increased when the surface was UV-treated (62.8 ± 3.0%) or the increased curing 
conditions were used (60.8 ± 1.8%). This effect wasnot additive, however, as no 
difference was observed between untreated and UV-treated surfaces after increased 
curing. None of the surfaces performed as well as Mtrigel-coated polystyrene, which 




 TUNEL staining was highly variable across all cultures. However, a trend was 
observed. UV treatment of the PDMS cured at the lower baking temperature significantly 
decreased the percentage of TUNEL-positive cells, as did the increased curing 






































FIGURE 2.3: UV Treatment and Increased Curing Improved hES Cell 
Maintenance of Pluripotency and Decreased Cell Death at Two Days 
Matrigel-coated polystyrene control was the best growth condition for hES cells, with 
significantly higher OCT4 expression and lower leves of TUNEL staining as compared 
to any PDMS surface. UV treatment and increased curing conditions improved both 
measures over lightly cured, untreated PDMS. No difference was observed between 
untreated and UV-treated surfaces after increased curing. Data represented as mean ± 
SEM. n=2,3,3,2,3.  












2.3.2: UV Treatment and Increased Curing Conditions Improve hES Cell Yield at Five 
Days on PDMS 
  
 After five days of growth, hES cells on control polystyrene surfaces became too 
overgrown to accurately quantify. Cells on PDMS surfaces still grew as largely OCT4-
positive colonies, but some were also overgrown, with cells in the center of large colonies 




FIGURE 2.4: Representative hES Cell Growth on PDMS Surfaces at Five Days 
DAPI (blue, cell nuclei), OCT4 (red, pluripotency), and TUNEL (green, cell death) 
staining of cells as a function of PDMS treatments. Cells grew as primarily as large 
OCT4+ colonies. Some colonies had grown so large that differentiation, as assessed by 
staining and morphologic criteria, began in the centers of the colonies. Larger 
percentages of cell death were observed on lightly cured, untreated surfaces 
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 Because of the overgrowth, comparing the percentag of OCT4-positive cells at 
this time point would be inaccurate. Instead, we looked at the total number of cells 
present and the percentage of TUNEL-positive cells. The numbers of both colonies and 
total cells were lower on lightly cured, untreated PDMS surfaces as compared to the other 
conditions. Some colonies were well over 1000 cells and this is likely the result of both 
colony growth and merging. As with 2 days, the averg  colony size was unchanged by 
PDMS treatment (Table 2.2). The distribution of colony sizes was similar across all 
conditions, although the lightly cured, UV-treated PDMS had a sharper peak in the 100-
500 cell range (Figure 2.5). 
 
 
TABLE 2.2: UV Treatment and Increased Curing Increased the Numbers of 
Colonies and Total Cells at Five Days on PDMS 
 
Condition # Colonies  Total Cells Average Colony Size 
Light curing, untreated 83 26383 281 
Light curing, UV 209 57730 239 
Increased curing, untreated 234 49917 237 
Increased curing, UV 217 62513 206 
 
Pooled data from two experiments are shown. A lower number of colonies and total cells 
were found on the lightly cured, untreated surfaces, but no difference in average colony 



































FIGURE 2.5: Human ES Cell Colony Size Distribution on PDMS was not 
Affected by Increased Curing or UV Treatment at Two Days 
Data shown are pooled from two experiments. 5 days after seeding, colony sizes ranged 
from under 10 to over 2000 cells.. Data points represent the percentage of quantified 
colonies at or below the plotted size. Lower numbers of colonies of each size were 
observed on the lightly cured, untreated surfaces as compared to increased curing or 
UV-treated conditions, but the percentage distribution of each was similar.  LC = lightly 
cured, IC = increased curing, NT = not treated, UV = UV-treated. 
 
 
 While the percentages of OCT4-positive cells were aff cted by cell overgrowth 
and its tendency to induce differentiation, overgrowth did not increase cell death as 
measured by TUNEL staining. There was a great deal of variation between experiments, 
so statistical analysis of the mean percentages of TUNEL-positive cells is affected by 
high variability. Data are also pulled from only two independent experiments, making 
such comparisons inappropriate. Data from these two experiments were pooled and 
compared using a Chi square test. Cells grown on lightly cured, untreated surfaces 
exhibited ~9.9% cell death. UV treatment significantly lowered TUNEL positivity to 





















FIGURE 2.6: UV Treatment and Increased Curing Improved hES Cell Survival at 
Five Days on PDMS 
The percentage of TUNEL-positive cells was significantly lower after UV treatment or 
increased curing conditions as compared to lightly cured, untreated surfaces. Data are 
represented as mean ± SEM. n=2.  




2.3.3: Differences in hES Cell Maintenance on Treated PDMS Surfaces Are Not Related 
to Surface Topography 
 
 AFM was used to measure the surface roughness of at least two of each of the 
PDMS surfaces studied. A 10 µm square area was measured at a scan rate of 0.565 Hz. In 
each case, the average surface roughness was approximately 1 nm. Thus, neither the 
curing conditions used nor the UV treatment seem to alter the roughness of the PDMS 
surface. The observed differences in hES cell behavior re therefore unlikely to be a 








 We have demonstrated impaired survival, maintenance of pluripotency, and 
growth of hES cells on lightly cured, untreated PDMS surfaces. UV treatment or 
increased curing conditions improved these end-points, but the mechanism is unclear. UV 
treatment has been shown to increase smoothness at the surface of PDMS,84, 146 but we 
measured no difference in this parameter after treatm nt. UV treatment may also have 
increased the hydrophilicity of the surface by decreasing the number of methyl groups 
and increasing the number of hydroxyl groups presented.84, 85 A qualitative increase in 
surface wettability after UV treatment was observed during Matrigel coating, with a 
greater increase noted in plasma treated surfaces. Th e differences were expected, but 
were not quantified in this study.  
 An increase in surface hydrophilicity may have altred the conformation of the 
ECM proteins adsorbed on the surface, thus changing the attachment sites and signaling 
cues available to hES cells. Matrigel is a complex ECM mixture, including laminin, 
enactin, collagen IV, fibronectin, and fibrinogen, among others.147 Individually, laminin 
and collagen IV both form ordered networks and better support human umbilical vein 
endothelial cell growth when coated on ethyl acrylate that either has low levels of 
hydroxyl groups or is saturated with them. These surfaces were less supportive of cell 
growth when they incorporated a complete lack of -OH groups or more intermediate 
levels.138 The change in conformation of these two ECM proteins on -OH-saturated 
surfaces may explain the poor results we obtained when using PDMS surfaces treated 
with air plasma (data not shown). In a study employing SAMs coated with fibronectin, 
Keselowsky et al.133 demonstrated an increased availability of α5β1 integrin binding sites 
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on surfaces presenting -OH groups. However, a slightly less hydrophilic surface 
presenting -COOH groups also presented αv binding sites, suggesting that a surface 
saturated with -OH groups may not be optimal for hES cells, which normally express 
both α5 and αv integrin subunits. When laminin isoforms are used to support hES cell 
growth, α6β1 integrins are necessary.54 Because of the complex mixture found in 
Matrigel, it is likely that hES attachment and growth can be mediated through a number 
of integrin binding sites found on various ECM proteins. It is important, however, that 
the adsorbed proteins from the Matrigel mixture are presenting ample sites for at least 
one of the integrins employing the β1 subunit, as blocking this subunit has been shown t 
reduce hES cell attachment and proliferation on Matrigel-coated surfaces.53 
 Both UV treatment and increased curing conditions may have increased the level 
of crosslinking in the PDMS surfaces, thus decreasing the number of LMWS that could 
leach into the cell culture medium. UV is a surface treatment, but it may achieve deeper 
penetration into the bulk polymer than plasma treatment.136 Increased curing would be 
expected to increase crosslinking and decrease the number of LMWS throughout the bulk 
polymer. The exact effects of LMWS from PDMS in cell culture have not been 
elucidated, but the presence of such species in the cell membranes of cells grown in 
PDMS-based devices is troubling.83 In addition to possible disruption of signaling at the 
cell membrane, LMWS may interact with components of the medium and affect cell 
growth in a number of ways.  
 Increased crosslinking may also increase hydrophobic molecule partitioning from 
the culture medium.83 This is unlikely to be a concern in this study, where the surface 
area to volume ratio (SA/V) was low. However, it is a concern that will need to be 
 
 31
addressed in future studies, as SA/V in microfluidic evices is usually significantly 
higher and may allow for this process to significantly affect the concentration of medium 
components. 
 At 2 days, the effects of the UV treatment and increased curing conditions were 
very similar and did not appear to be additive. At 5 days, however, UV treatment 
appeared to increase the overall cell yield regardless of the curing conditions. Our sample 
size is small, so it is difficult to determine whetr the two treatments may provide 
additive effects. However, it is clear that lightly cured, untreated PDMS is not a suitable 
growth surface for hES cells. The average colony size and the distribution of colony sizes 
were similar on all of our PDMS surfaces. This suggests that the primary problem 
presented by lightly cured untreated PDMS may be impa red cell attachment, rather than 
proliferation. Cells that were able to attach were also able to proliferate. We also 
observed a lower percentage of OCT4-positive cells on these surfaces at 2 days. It is 
possible that a lack of proper integrin binding site  or the presence of LMWS biased 
these cells towards differentiation, rather than self-renewal. 
 While both UV treatment and increased curing conditions had a positive effect on 
the maintenance of pluripotent hES cells in culture, none of the PDMS surfaces supported 
growth as well as polystyrene. There are now a number of synthetic or defined surfaces 
available for the culture of hES and hiPS cells, but these are quite often coatings on 
polystyrene and are generally compared to Matrigel when assessing their ability to 
maintain cell growth. A surface that does not support ample cell growth when coated 
with Matrigel likely will not do so with the newer synthetic coatings. Further treatment of 
the PDMS will thus be necessary to mitigate negative effects on hES cells. If LMWS are 
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contributing to increased cell death and decreased pluripotency in cultures, it is possible 
that further extending the curing time may improve growth.83 Other treatments, such as 
extraction processes or silica coating148, may also be beneficial. The latter would also 
help to prevent hydrophobic molecule partitioning, if that is a concern. 
 We provide a first examination of the growth of hES cells on PDMS surfaces. 
From this investigation, it is clear that PDMS is far rom ideal and has negative effects on 
survival and maintenance of pluripotency in hES cells. These effects will need to be 
countered or better understood in order to compare results from PDMS-based 




CHAPTER 3: Maintenance of Human Embryonic Stem Cells is Improved by 




 In vivo, oxygen (O2) levels vary widely within and between tissues. The level of 
O2 in a given cell is determined by its proximity to blood vessels, the level of 
vascularization, and the O2 demands and use of the tissue. The O2 tension in most tissues 
ranges from 2-9%, with some tissue areas as low as 1% or as high as 14%.86 During 
development prior to vascularization, O2 tension in the embryo is dependent on diffusion 
from extraembryonic sources. In cell culture, however, the O2 tension is generally 
dictated by that in air (~21% O2) , with gas tanks used only to supply CO2 . With the 
addition of 5% CO2 for buffering, most cell culture is then carried out at ~20% O2, a level 
that is physiologically hyperoxic for all mammalian tissues.  
 Lowering the O2 tension of cell culture to more physiological levels has profound 
effects on various cell types. When placed in 20% O2, some differentiated cell types lose 
function and revert to a more fibroblast-like state. Lowed O2 tension in the culture of 
chondrocytes leads to improved formation of cartilage in vitro.87-89 Similarly, smooth 
muscle cells retain a more contractile phenotype whn O2 tension is held at more 
physiologic levels.90-92 Lowered O2 in tissue culture also has prominent effects on various 
resident stem cell populations, and it is important o note that stem cells often reside in 
low O2 niches within tissues. One reason for this localization is that these niches 
potentially help protect stem cells from incurring too much oxidative damage over time.86 
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Reactive oxygen species (ROS) accumulated over time can cause DNA damage leading 
to early cell senescence or death.  
 Positive effects of lowered O2 in culture have been reported in a number of adult 
stem cell types,149 including neural stem cells,95, 96 myoblasts,97 mesenchymal stem 
cells,98, 150 and marrow-isolated adult multilineage inducible (MIAMI) cells.99 Lowered 
O2 tension can also increase proliferation and stem-like properties in glioblastoma cancer 
cells.100 Physiologic O2 in stem cell culture can provide an environment in which stem 
cells are better maintained undifferentiated, as well as one in which specific cell types 
can be efficiently differentiated, and both can be tru  of the same stem cell. As an 
example, rat mesencephalic precursor cells growth at 3% vs. 20% O2 showed 
significantly greater levels of proliferation and lower levels of cell death. When these 
cells were differentiated into neurons in lowered O2 (3%), 56% of neurons were 
dopaminergic, as compared to only 18% when differentiated in 20% O2.
95   
 While there is not a uniform consensus,151 there is a great deal of evidence that 
physiologic O2 levels are beneficial in the growth of hES and hiPS cells. Placental O2 
tension in the first trimester of pregnancy has been m asured at below 3% O2, with levels 
in the endometrial lining never exceeding ~5%.152 One would expect that O2 levels in the 
pre-implantation blastocyst, which are determined solely by diffusion from uterine 
tissues, would be even lower. In fact, both bovine153, 154 and human155, 156 blastocysts 
show improved yield, growth, and quality when grown at lowered O2 tensions and IVF 
clinics routinely culture human blastocysts in 5% O2. It is thus unsurprising that positive 
effects of lowered O2 have been reported in cultured hES and hiPS cells. When grown at 
lowered O2 tension (ranging from 1% to 12% in the literature), hES cells maintain higher 
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levels of pluripotency markers, recover better from clonal density plating, maintain 
longer telomeres, and display less chromosomal aberr tion.101-103  
 Lengner et al.104 demonstrated that derivation of female hES cell lines cultured in 
physiologic O2 tensions allowed cells to maintain two active X chromosomes, while all 
known lines derived and grown in 20% O2 show at least partial X inactivation. When 
their lines were chronically exposed to high (20%) O2, irreversible X inactivation 
occurred. The maintenance of two active X chromosomes represents a less differentiated 
phenotype and is maintained in mouse ES cells. This study indicates that culture at 20% 
O2 permanently alters hES cells from the state found in the ICM. In contrast to other 
studies,101, 103 Lengner did not observe a reduction in gene expression of pluripotency 
markers when growing hES cells at 20% O2, but did observe an increase in more 
differentiated markers. Human ES cells grown in high O2 conditions were more likely to 
differentiate in combination with suboptimal culture conditions in which cells were 
allowed to grow for 8 days without passaging. Similarly, Yoshida et al.157 showed that 
hiPS derivation from fibroblasts is more efficient when carried out in 5% O2, rather than 
in room air oxygen.  
 Lowered O2 tension in culture is generally achieved using either small chambers 
(modular incubators) or full incubators purged with nitrogen. Ideally, these set-ups 
require calibrated O2 sensors and the use of nitrogen gas tanks, both adding to the 
expense of tissue culture. Complete enclosed culture systems with controlled gas 
environments allow cells to be cultured and manipulated without being exposed to high 
levels of O2 during feeds or passaging. These provide a better platform for continuous, 
controlled low O2 culture, but are expensive platforms. Because of the expense and labor 
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required to vary O2 tension in culture, studies in which O2 is the important variable 
usually examine only one or two O2 tensions compared to room air O2, without sampling 
the full phsyiologic range. In the references cited above, for example, O2 tensions used 
ranged from as low as 1% to as high as 12%. It can thus be useful to have a system in 
which multiple O2 levels can be tested at once before choosing an optimal O2 level for 
specific culture outcomes.  
 Traditionally, oxygen gradients have been created by growing cells (generally 
bacterial) in suspension at an air-liquid interface (either in a capillary or by creating a 
bubble) at which a gradient can form.158-160 The highest level of O2 can be modulated by 
altering the oxygen level within the gas at the intrface. However, it is technically 
difficult to quantify responses to this O2 gradient, as suspension cultures cannot be fixed 
and stained in a way that preserves spatial positioning. Furthermore, this method implies 
that cells will be grown in suspension culture and is therefore difficult to apply to most 
mammalian cells that depend on attachment for survival. Achorage-dependent 
mammalian cells can undergo a programmed cell death process known as anoikis when 
detached from the ECM. Human ES cells are particularly susceptible to dissociation-
mediated cell death and are usually passaged in clumps. The addition of Rho kinase 
(ROCK) inhibitor to single-cell suspensions of hES cells has been shown to prevent cell 
death after dissociation, and this may be a functio of blocking the process of anoikis.161  
 Multiple microfluidics devices have been developed to present more controllable 
O2 gradients to adherent cultured cells that can thenbe analyzed using microscopy. These 
devices have employed varied strategies, including flat-plate fluid flow,162 gas interface 
with a permeable membrane over a flow chamber,160 and flow or reservoir chambers 
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filled with oxygen-scavenging substances separated from culture chambers by gas-
permeable membranes.121, 122 Although these devices usually have low rates of flow, the 
shear stresses they cause can still affect cell behavior,163 and these effects are then 
difficult to separate from those of the oxygen gradient. In addition, the creation of most 
microfluidics devices requires fabrication equipment a d techniques unavailable in most 
biology laboratories. Park et al.120, 164 designed a system which created a gradient using 
an electrolysis reaction to create O2 which then diffused through an O2-permeable 
polydimethylsiloxane (PDMS) membrane into the culture chamber. This device did not 
create fluid shear stress on the cells, but did requi  complex fabrication. In addition, the 
growth surface was a PDMS membrane, which can be toxic t  cells.124, 129, 137 In the 
preceding chapter, we investigated this toxicity in the context of hES cell culture. 
 We used a relatively simple diffusion-based device to present an O2 gradient 
spanning physiologic O2 levels to hES cells in culture. With the exception of a reusable 
acrylic frame (Appendix Figure A.1), the device and set-up were constructed without 
complicated fabrication techniques or equipment. Oxygen gradients applied for 24-60 
hours yielded results that were consistent with previous reports comparing a single low 
O2 level to 20% O2 . In the current study, the lower O2 regions of the gradient contained 
more cells than the higher O2 regions and a greater percentage of cells in lower O2 
regions expressed pluripotency markers. We were able to determine that O2 levels below 
5% better mediated these pro-survival and pluripotency outcomes as compared to higher 





3.2.1: Oxygen Gradient System 
  We used a relatively simply constructed diffusion-based system to culture hES 
cells in a defined O2 gradient. This system consisted of an anoxic chamber with circular 
culture wells containing an O2-permeable center. The growth surface was a thin sheet of 
polystyrene in which small holes (r=0.75 mm) were punched using a disposable biopsy 
punch (Premier Medical, Charlotte, NC). These holes w re then sealed with a thin film of 
PDMS, a highly O2-permeable polymer,
165 and a small section of cross-linked 
polyethelene (PEX) tubing with an inner diameter of 1.1 cm was centered around the 
PDMS and affixed to the polystyrene, creating a culture well (Figure 3.1). This set-up 
was then placed in a sealed chamber (Bud Industries, Willoughby, OH), with the PDMS-
covered holes open to the ambient atmosphere inside a standard incubator (37oC, 5% 
CO2, 20% O2). The chamber was constantly purged with a humidifie  gas mixture (5% 
CO2, 95% N2) to achieve 0% O2 inside the chamber. Gas flow from the outlet was 
checked periodically during experiments by placing the outflow tube in a container of 
water to check for bubbling. Oxygen was thus delivered by diffusion through the PDMS-
covered center of the culture well, yielding a natur l gradient (Figure 3.1). Oxygen 
diffusion within the culture wells was modeled using a 2D axi-symmetric model in 








FIGURE 3.1: Oxygen Gradient Cell Culture Device 
A. Schematic of the O2 gradient set-up. A gas mixture was bubbled through a sealed 
container of sterile water in order to humidify it. This gas was then used to purge the 
chamber and make the interior anoxic. O2-permeable PDMS at the center of each culture 
well allowed O2 from the ambient environment in the incubator to diffuse into the culture 
well. This entire set-up was placed in a standard incubator at 20% O2, 5% CO2, and 
37oC. B. A picture of an assembled device before it is sealed. Scale bar is 1.1 cm. Inset: 
One gradient culture well. C. COMSOL Multiphysics® imulation of O2 levels from the 
center of a well (highest O2) outward. Levels range from ~1% at the outer edge of the 









3.2.2: Resazurin Visualization of O2 
 Simulations suggested that the O2 gradient reaches steady-state in approximately 
10 minutes after the onset of gas flow. We used resazurin, an O2-sensitive dye, to 
visualize the changes in O2 tension within the chamber. The procedure followed as 
similar to that described in Park et al.120 The resazurin solution consisted of 1 M NaOH, 
0.3 M glucose, and 0.1% resazurin. This solution is colorless in the absence of O2 and 
blue in its presence, with an intensity proportional to the level of O2 available. The 
solution was loaded into wells in which the O2 gradient was established and into control 
wells without the O2-permeable center. The chamber was then sealed and gas flow was 
started. Pictures of the wells were taken before the onset of gas flow through the chamber 
and again at 5, 10, 15, and 20 minutes of flow. 
 
 
3.2.3: Human ES Cell Culture 
 For hES cell experiments, H1 cells (p35-50, WiCell Madison, WI) were 
maintained on a mouse embryonic fibroblast (MEF) feeder layer, on growth factor 
reduced Matrigel-coated dishes (BD Biosciences, Sparks, MD) with MEF-conditioned 
medium (MEF-CM), or on hES-qualified Matrigel (BD Biosciences) in mTeSR®1 
medium (Stem Cell Technologies, Vancouver, BC, Canad ). Cells were manually 
passaged except in mTeSR®1 medium, when dispase was used. When cells were grown 
on MEFs, they were treated with accutase (Invitrogen, Carlsbad, CA) for 20 minutes at 
37oC. They were then pre-plated in MEF conditioned medium (MEF-CM) with 10 µΜ 
ROCK inhibitor (Y-27632, Sigma-Aldrich, St. Louis, MO) on gelatin-coated plates for 1 
hour, allowing MEFs to adhere while most hES cells remained in suspension. Human ES 
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cells were then rinsed and plated in MEF-CM supplemented with 10 µΜ ROCK inhibitor 
and 10 ng/ml basic fibroblast growth factor (bFGF, R&D Systems, Minneapolis, MN). 
Cells grown in feeder-free conditions were treated with accutase for 15 minutes and 
plated for experiments without a pre-plating step. Cells were seeded as single cells at 
~35,000 cells/cm2 and allowed to adhere for at least 12 hours before the medium was 
changed to MEF-CM with bFGF, but without ROCK inhibitor. Culture wells were 
checked for even seeding before the gradient was begun. For experiments lasting longer 
than 24 hours, medium was changed daily. For proliferation measurements, 50µΜ 
bromodeoxyuridine (BrdU) was added to the culture medium for the last hour of culture. 
 
3.2.4: Immunocytochemistry For Pluripotency Markers, TUNEL, and BrdU 
 Once the gradient was completed at 24 or 60 hours, cell  were fixed in 4% 
paraformaldehyde (PFA). TUNEL and OCT4 staining were carried out as described in 
section 2.2.3. The PEX wells were then removed and the area was coverslipped using 
Vectashield with DAPI (Vector Labs, Burlingame, CA) to counterstain nuclei and protect 
the fluorescent signal. For BrdU and nanog staining, cultures were post-fixed in 100% 
methanol, treated with 2 N HCl, neutralized with borate buffer, treated with Triton-X-
100, and blocked in 1% fish gel. Primary antibodies (BrdU - AbD Serotec, Oxford, UK; 
Nanog - Cell Signaling, Danvers, MA) were applied overnight at 4oC at a 1:400 dilution 
in PBS. Cy3- or Alexafluor-conjugated antibodies were applied for 1-2 hours at RT. This 
staining protocol adversely affects fluorescent imaging in the blue spectrum when stains 
are coverslipped. For this reason, Hoechst 33324 was used to counter-stain nuclei and 
imaging was carried out in PBS, without coverslipping. 
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 Imaging was carried out with fluorescent microscopy. Culture wells were 
photographed beginning at the center and moving to the edges in 3-4 directions, with 
successive images overlapping. These images were thn used to build a composite picture 
of the entire gradient using Adobe Photoshop (Adobe Systems Incorporated, San Jose, 
CA). These composite pictures were split into four equal sections roughly corresponding 
to 5-12%, 3.5-5%, 2.5-3.5%, and 1-2.5% O2. The number of cells stained for each marker 
was counted using ImageJ, with at least 3 composite pic ures quantified per sample. The 
cell number in each section is reported as a percentag  of the total cells along the 
gradient. Because of variation between experiments, the percentages of cells stained for 
markers of interest (OCT4, TUNEL, nanog, and BrdU) were normalized to the total 
percentage of these markers across the gradient. Measurements are reported as mean ± 






3.3.1: Steady-State O2 Levels are Quickly Established in the O2 Gradient Device 
 The resazurin solution was dark blue to purple when loaded into the culture wells. 
Once the gradient was started, this color was lost, c nfirming a lack of O2 in the wells 
after nitrogen purging. By five minutes, the solution was essentially colorless in control 
wells that had no O2-permeable surface. The resolution of the colorimetric change and 
photography used were unfortunately not high enough to visualize the gradient, but it is 
still apparent that a higher level of O2 is maintained at the center of the gradient well 
(Figure 3.2). This result supports the COMSOL simulation which resulted in a steady-





FIGURE 3.2: Steady-State O2 Levels are Quickly Established in the O2 Gradient 
Device 
Resazurin was used as an O2-sensitive dye. Anoxic conditions within the chamber were 
confirmed by this dye within 5 minutes of gas flow. The resolution was not high enough to 
visualize the gradient, but an area of higher O2 can be seen in the center of the gradient 
well throughout the time course. 
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3.3.2: Human ES Cell Maintenance is Improved at Low Oxygen 
 Cells were able to adhere to and grow on the Matrigel-coated polystyrene 
surfaces, despite the fact that these surfaces were not tissue culture treated. A typical 
result of a gradient run for 24 hours and stained for OCT4 and TUNEL is shown in 
Figure 3.3.  
 At 24 hours, there was a difference in the distribu ion of the cells as a function of 
O2, with a significantly higher number of cells in the lowest range of O2 tensions (~1-2.5) 
as compared to the rest of the gradient regions. TUNEL staining revealed a trend towards 
lower levels at lowered O2, but this difference was not statistically significant. BrdU 
staining was not different in subsections of the gradient, suggesting that proliferation at 
this time point is not affected by O2 in these physiologic ranges. The possibility that cells 
migrated into the regions of lowered O2 cannot be ruled out. The percentage of OCT4-
positive cells was significantly lower in the highest range of O2 tension (5-12%) as 
compared to those below 5%. Similar results were observed with Nanog staining. These 













FIGURE 3.3: Human ES Cells Grown on an O2 Gradient for 24 Hours 
Typical staining results of hES cells maintained on an O2 gradient for 24 hours. DAPI 
(blue, nuclei), OCT4 (red, pluripotency), and TUNEL (green, nicked-end DNA) are 
shown. Oxygen levels decrease from approximately 12% at the far left to 1% at the far 
right. The total number of cells and the co-localiztion of OCT4 and TUNEL with DAPI 
were quantified as a function of local O2 tension. A significantly greater number of cells 
were observed in the range from 1-2.5% O2. A significantly lower percentage of OCT4+ 









FIGURE 3.4: Pluripotent hES Cells are Better Maintained in Lower vs. Higher O2 
Regions of an O2 Gradient at 24 Hours 
A summary of the data from application of the O2 gradient to hES cells for 24 hrs. A 
significantly higher proportion of cells were found in the lowest O2 levels. A greater 
percentage of cells grown in O2 levels below 5% expressed OCT4 than in those above 
and a greater percentage of cells grown in O2 levels below 3.5% expressed nanog. A 
trend towards lower levels of cell death was observed in the lowered O2, but this was not 
statistically significant. *p<0.05, **p<0.01, ***p<0.001.  
 
 
 After exposure to the O2 gradient for 60 hours, the number of cells at the lowest 
range of O2 tensions was no longer significantly greater than all other sections, but the 
general pattern of greater numbers of cells at lower vs. higher O2 levels persisted. The 
three quadrants presenting less that 5% O2 each contained significantly more cells than 
the quandrant presenting 5-12%. A significantly higher percentage of cells in the 2.5-5% 
and 1-2.5% quadrants expressed OCT4 compared to those in the 5-12% quadrant. No 
statistical differences were observed in TUNEL staining as a function of O2 levels. These 




FIGURE 3.5: Pluripotent hES Cells are Better Maintained in O2 Levels Below 5% 
After 60 Hours in an O2 Gradient 
A summary of data from application of the O2 gradient to hES cells for 60 hrs. A 
significantly lower number of cells were found at the highest levels of O2 (5-12%) as 
compared to all other regions. The highest levels of OCT4 expression were still observed 
in O2 tensions below 5%. No significant trend was observed in TUNEL staining at this 
time. *p<0.05, **p<0.01, ***p<0.001. 
 
 
 When hES cells were grown to confluence in this system, they invariably began 
peeling off the growth surface in sheets. This peeling was independent of gradient 
application and was not prevented by a sandwich culture with a second layer of Matrigel 
applied over a nearly confluent monolayer. Peeling may have been due to a number of 
factors, including the small culture surface area, incompatibility of the cells with a 
polystyrene surface that was not tissue culture treated, or the pliancy of the thin 
polystyrene sheets. Whatever the cause, the detachment of cells grown to confluence 
rendered experiments examining cell behavior over longer time periods impossible. For 
example, neural differentiation (as described in Chapter 4) requires growth in a confluent 






 We have demonstrated the use of a diffusion-based device for culturing hES cells 
in a fairly well defined O2 gradient in the physiologic range. The use of this device does 
not subject the cells to shear stresses and does not require expensive fabrication 
equipment, making it accessible to biology laboratories. Control of the O2 levels is not 
precise, but the device does provide a rough screen of multiple O2 ranges and can thus be 
used to provide a starting point within the physiologic range of O2 levels that can be used 
to optimize the culture environment of a particular cell type. Our results are consistent 
with those of other studies in which hES cells were cultured in more traditional 
conditions (20% O2) or in a single lower O2 tension. In our experiments, the highest 
levels of O2 (~5-12%) always yielded the least desirable results. The largest number of 
cells and percentages of pluripotency markers were found at O2 levels below 5%. Thus 
the device helped to distinguish survival and expression patterns of cells in O2 levels that 
have been referred to as "mild hypoxia" (12%)103 vs. even lower ranges that are closer to 
normal in vivo environments.  
 Maintenance of hES cell pluripotency at lowered O2 levels is likely at least 
partially mediated through hypoxia-inducible factor 2 alpha (HIF2-α), which is known to 
directly regulate OCT4 expression.166 OCT4 regulates pluripotency of hES cells in a 
complex feedback system with nanog and (sex determining region Y)-box 2 (SOX2).167 
Physiologically hyperoxic O2 tensions may disrupt this feedback loop, leading to reduced 
pluripotency. In a microarray analysis of hES cells at 4% and 20% O2, Westfall et al.
168 
did not find a direct effect of O2 on OCT4 or nanog expression, but did find that 
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downstream effectors of both transcription factors were reduced in 20% O2. They also 
observed an increase in some genes associated with ifferentiation as well as oxidative 
stress as a function of high O2.  
 Accumulation of reactive oxygen species (ROS) may also be a factor in the loss 
of pluripotency at high O2 tensions. Human ES cells grown with a glutathione inhibitor to 
enrich the levels of ROS in culture exhibited decreases in pluripotency markers, 
including OCT4, nanog, and SOX2.169 Additionally, markers associated with endodermal 
and mesodermal differentiation were upregulated. These responses were at least partially 
reversed by the addition of Vitamin C, a free radicl scavenger, supporting a role for 
ROS in inducing spontaneous differentiation of hES cells. 
 A limitation of this study is that we did not have the capacity to measure O2 levels 
in the gradient. We used a simulation to provide estimations, but this simulation did not 
account for cell consumption of O2, which can vary significantly between cell types. Cell 
consumption of O2 can create a gradient even in a microfluidics system in which the 
medium is constantly refreshed,170 so it is reasonable to assume that it will affect the 
levels experienced by cells further from the center in our diffusion-based system. 
Polystyrene can be combined with platinum(II) octaethylporphyrine ketone (PtOEPK) in 
a thin film that provides O2-sensing capability using fluorescent microscopy.
171 This 
method may be useful in obtaining a more accurate model of the O2 gradient produced 
here. 
 This device could also be used to more closely replicate situations in which an O2 
gradient is normally present in vivo. An example relevant to Chapter 4 is reperfusion after 
ischemic stroke. Oxygen and glucose deprivation (OGD)172 is a commonly used in vitro 
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model of stroke. Using this method, cultures of neurons are subjected to deprivation of 
oxygen and glucose for a set period of time, followed by a reperfusion phase in which 
cells are placed back into glucose-containing medium and standard culture conditions 
(usually 20% O2). Use of the O2 gradient after OGD could better mimic reperfusion, after 
which some areas of the tissue will be better oxygenated than others. Cells transplanted 
into the stroke region are also expected to encounter an O2 gradient, so this device may 
be useful in predicting the range of responses that cells will demonstrate as a function of 
exposure to the range of O2 tensions in the reperfused stroke region. 
 hES cells are relatively difficult to culture, particularly as single cells. The ability 
to successfully culture them at subconfluent levels on this device suggests that many 
more robust cell types will remain viable when cultured in this O2 gradient. The 
responses of other cell types to varied O2 levels can thus be investigated in the same 
manner we describe here. We provided a proof-of-concept of the utility of this device and 
confirmed reported effects of lowered O2 tensions on hES cells, suggesting that this 
simple device can be used to investigate additional cellular responses to O2. In addition, 




CHAPTER 4: A Small-Molecule Based Protocol to Derive Neural Progenitors and 





4.1.1: Neural Differentiation of hES and hiPS Cells 
 Human ES and hiPS cells provide an unmatched windo into early human 
development and pluripotency makes them very attractive sources for cell and tissue 
replacement therapies. Cell replacement therapies are widely studied for the treatment of 
neurological injuries and disorders where the capacity for self-renewal is limited. 
However, directed differentiation of pluripotent cells is still difficult, even in the case of 
neural differentiation, which is seen as the default pathway for these cells.173  
 Neural differentiation protocols often involve suspension culture105, 174-178 or co-
culture with feeder cells,176, 179, 180 both of which can introduce heterogeneity in 
microenvironmental cues. In addition, expensive recombinant factors are often used. 
Noggin, a recombinant bone morphogenetic protein (BMP) inhibitor, is a commonly used 
factor in induction of human cells to neural progenitors.174, 181-183 For terminal neural 
differentiation, expensive growth factors like brain-derived and glia cell-derived 
neurotrophic factors (BDNF and GDNF) are often used in ifferentiation processes that 
take several weeks.176, 178, 179, 184-186 The expense associated with recombinant proteins is a 




 Chambers et al.182 provided a fully adherent differentiation protocol useful for 
efficient generation of neuroepithelial cells from hES and hiPS cells through inhibition of 
the SMAD pathway, This protocol removed the heterogneity inherent in suspension 
cultures, but required both a small molecule transforming growth factor beta (TGF-β) 
inhibitor known as SB431542 and the recombinant factor noggin. Dorsomorphin, also 
known as Substance C, is a small-molecule BMP inhibtor that enhances neural induction 
in suspension175, 176 and co-culture176 models. It has also been used to induce cardiac 
differentiation in mouse ES cells.187 Recent work has shown that dorsomorphin alone 
may be sufficient to effect neural differentiation in hES and hiPS cells, by affecting BMP, 
TGF-β, activin, and muscle segment homeobox 2 (MSX2) pathw ys.186 
 We used dorsomorphin and SB431542 in a fully adherent neural differentiation 
protocol. Unlike many previous studies in which similar methods were used, we 
examined the electrophysiological properties of neurons derived from our neural 
precursors in vitro, in addition to molecular changes associated with terminal neuron 
differentiation. Notably, we quickly generated functional neurons without BDNF or 
GDNF, in a culture system which we believe will be generally useful for study in neural 
development. Portions of this work have been accepted for publication in the Journal of 
Stem Cells.188 
 
4.1.2: Ischemic Stroke  
 Stroke is the third leading cause of death and a leading cause of disability in the 
United States. On average, someone in the US has a stroke every 40 seconds, with 
~795,000 per year. Of these, 87% are ischemic strokes in which blood flow is cut off to 
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an area of the brain. Stroke accounts for 1 in 18 deaths in the US, with 8-12% of patients 
dying within the first month. Of those who do survive, 15-30% are permanently disabled. 
The costs associated with stroke in the US are estimated at $40.9 billion per year.189 
 Ischemic stroke generates multiple toxic effects, including energy failure, 
acidosis, glutamate release and excitotoxicity, generation of free radicals (especially after 
reperfusion), blood brain barrier (BBB) disruption, and inflammation.190 Little progress 
has been made in preventing or reversing the cell damage and death induced by these 
signals. The only approved treatment for thromboembolic ischemic stroke is tissue 
plasminogen activator (tPA), which must be given in the acute phase of injury to be 
effective in breaking up the clot causing vascular obstruction. Many drugs that mediate 
significant neuroprotection in animal models have failed in clinical trials. Erythropoietin 
(EPO), for example, seemed promising in a limited trial where tPA was not used, but 
subsequently failed to improve outcomes and may even have been detrimental when 
combined with the gold-standard tPA treatment in a larger study.191   
 Ischemic stroke models in rodents vary both in the duration and the method used 
to induce stroke. Embolic stroke models generally involve the injection of some sort of 
material, often autologous clots, to block a major feeder artery to the brain. These models 
closely mimic the clinical situation, but are highly variable.190 As a result, middle 
cerebral artery occlusion (MCAO), which is much more repeatable, is a common stroke 
model. Occlusion is most often achieved by inserting a suture or filament into the MCA, 
possibly blocking some of its branches as well.192-194 Stroke size and location vary based 
on the time course of occlusion, which can be transient or permanent, and the exact 
branches of the MCA affected. We used the mini-stroke model developed by Wei et 
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al.,195-197 in rats and later, mice.198 This stroke model involves both the permanent ligation 
of 2-3 branches of the MCA and transient occlusion of the bilateral common carotid 
arteries (CCA). The advantage of this model is thatit results in a small, reproducible 
stroke area primarily affecting the barrel cortex. 
 
4.1.3: Cell Therapy for Stroke 
 Acute treatments for stroke are generally focused on removing the cause of the 
stroke (often a clot) and providing neuroprotection t  avoid the continuing cell death that 
occurs after reperfusion injury. In the chronic phase of stroke, the goal is to repair lost 
tissues and recover lost function. Cell therapy is an attractive strategy for treating chronic 
stroke patients due to the possibility for both trophic support leading to increased 
endogenous recovery and replacement of damaged or dead cells.199-201  
 A great deal of research has focused on the use of mesenchymal stem cells 
(MSCs) derived from the bone marrow or umbilical cord blood in treating 
neurodegenerative disorders. While MSCs can differentiate into neuronal cells,202-204 their 
mechanism of action in the context of ischemic stroke is not true regeneration. MSCs are 
most often given intravenously, with very few cells crossing the blood brain barrier 
(BBB) and engrafting205 and appear to provide neuroprotection primarily through 
secretion of trophic factors and suppression of inflammation, even if significant numbers 
of cells do not cross the BBB.206, 207 The brain is generally considered to be immune 
privileged, but the disruption of the BBB caused by stroke and the inflammatory signals 
released by the microglia and astroycytes can lead to leukocyte invasion and increased 
cell death that may be mollified with immune suppression treatments.208 However, there 
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is also a natural immune suppression after stroke that leads to increased rates of infection 
in stroke patients that may be worsened by exogenous suppression. 
 When true regeneration is the goal of cell therapy in stroke, neural precursors will 
generally be used. Various types of neural precursors have been used in experimental 
models, including a conditionally immortalized cell line derived from human fetal tissue 
(now in clinical trials),209, 210 lines derived from carcinomas,211, 212 fetal neuronal stem 
cells,213 mouse neural precursors derived from the post-stroke c rtex,214 and precursors 
derived from mouse215-217 or human218, 219 ES cells. Human ES and hiPS cells are both 
promising cell sources for such therapies, but there are fears of teratoma or 
teratocarcinoma formation if cells are karyotypically unstable1-3 or inefficiently 
differentiated.4 With hiPS cells, there is the further fear that incompletely reprogrammed 
cells may remain persistently pluripotent, rather than differentiating, leading to teratoma 
formation.7 Teratomas are benign and generally stop growing as they mature, but damage 
to the surrounding tissues can be fatal, particularly in the confines of the skull.  
 We transplanted hES cell-derived neural precursors into a murine focal ischemic 
stroke model. These cells survived, engrafted, and differentiated into neurons in vivo. 
Cell transplantation also increased neurogenesis in the penumbra region of the stroke 
area, although it is not yet clear the extent to which this response was endogenous. 
Transplant animals demonstrated sensory improvement over time as measured by the 
adhesive removal test, while controls did not. These r sults demonstrate that our neural 
differentiation protocol can be used to derive functional neurons from pluripotent cells in 






4.2.1: Maintenance of hES and hiPS Cells 
 H1 and H9 ES (p35-60, WiCell Madison, WI) and human iPS (iPS-DF19-9/7T, 
WiCell) cells were cultured on hES-qualified Matrigel (BD Biosciences, Sparks, MD) in 
mTeSR®1 medium (Stem Cell Technologies, Vancouver, BC, Canada). Cells were 
observed and medium was changed daily. Cells were passaged every 5-7 days. Before 
passage, areas of differentiation were manually removed using a pipette tip. These areas 
were identified using a dissection microscope in a sterile hood. Cells were then rinsed 
with DMEM/F12 (Invitrogen, Carlsbad, CA) and treated with 1 mg/ml dispase (Stem 
Cell Technologies) for 5-7 minutes at 37oC. Plates were then rinsed with DMEM/F12 
before cell clumps were removed with a cell scraper and clumps were re-plated, typically 
at a 1:4 ratio. 
 Maintenance of pluripotency was tested by staining for pluripotency markers. 
Cells were fixed with 4% PFA. A blocking buffer consisting of 5% normal donkey serum 
(NDS) and 0.3% Triton-X 100 in phosphate buffered saline (PBS) was used at room 
temperature (RT) for 1 hour. Primary antibodies (Nanog, OCT4A, SOX2 - Cell 
Signaling, Danvers, MA) were applied overnight at 4oC at a 1:400 dilution in a 1% 
solution of bovine serum albumin (BSA) with 0.3% Triton-X 100 in PBS. Cy3- or 






4.2.2: In Vitro Differentiation of Neural Precursors 
 Neural induction was achieved using a modified version of the SMAD inhibition 
protocol described in Chambers et al.182 (Figure 4.1). Visible areas of differentiation were 
removed from hES or hiPS cell cultures, which were then rinsed with DMEM/F12. 
Cultures were treated with accutase (Invitrogen, Carlsb d, CA) at 37oC for 15 min and 
rinsed in DMEM/F12. They were then re-plated on growth-factor reduced Matrigel (BD 
Biosciences) coated plates at ~18,000 cells/cm2 and grown to confluence in MEF-
conditioned medium supplemented with 10 ng/ml bFGF (R&D Systems, Minneapolis, 
MN).  
 Cells reached confluence in 3-5 days and were then transferred to a neural 
induction knockout serum replacement (KSR) medium (Knockout DMEM, 15% KSR, 
1% L-glutamine, 1% NEAA, 1% penicillin/streptomycin, 50 µΜ β-mercaptoethanol, 
Invitrogen) supplemented with 3 µΜ dorsomorphin (Tocris, Ellisville, MO) and 10 µΜ 
SB431542 (Stemgent, Cambridge, MA). They were grown in this medium with daily 
medium changes for five days. The TGF-β inhibitor was then withdrawn and cells were 
exposed to increasing levels of N2 medium (DMEM/F12, 1:100 N2 supplement, 1% L-
glutamine, 1% penicillin/streptomycin, Invitrogen). For two days, the cells were grown in 
25% N2, 75% KSR medium supplemented with 3 µM dorsomorphin. The proportion of 
N2 was then increased to 50% for two days and then 75% for another two days. On day 







FIGURE 4.1: Small Molecule-Mediated Neural Differentiation Protocol 
Cells reached confluence after seeding in 3-5 days, followed by SMAD inhibition with 3 
µM dorsomorphin and 10 µM SB431542 for 5 days.  N2 medium was added at 25% on 
day 5 and increased at days 7 and 9. Neural precursors at day 11 were collected for 
analysis, transplanted, or passaged for terminal differentiation. Terminal differentiation 
was examined at 1,2,3, and 4 weeks after plating. 
 
 
 The level of differentiation was quantified by staining for neural precursor 
markers. Cultures were fixed with 4% PFA, post-fixed in a 2:1 mixture of ethanol:acetic 
acid, treated with 0.2% Triton-X 100, and then blocked with 1% fish gelatin. Primary 
antibodies (Nestin, 1:200 - Millipore, Billerica, MA; OCT3/4, SOX1, 1:100 - Santa Cruz 
Biotechnology, Santa Cruz, CA; PAX6, 1:100 - Covance, Princeton, NJ) were applied 
overnight at 4oC in PBS. Cy3- or Alexafluor 488-conjugated secondary antibodies were 
applied for 1-2 hours at RT. Hoechst 33324 or DAPI were used to counter-stain nuclei. 
Pictures were taken with fluorescent microscopy and quantified using ImageJ. Data were 
collected from at least 3 independent experiments ad the level of various markers is 









































4.2.3: In Vitro Differentiation of Neurons 
 After neural induction was completed, cells were treated with accutase for 30 
minutes at room temperature. Cells were scraped from the bottom of the plate and 
pipetting was used to break up clumps. Cells were then rinsed in DMEM/F12. In order to 
remove excess extracellular matrix and cell clumps, the cells were suspended in medium 
and filtered through a 20 µm mesh. They were then spot-seeded on Matrigel- or poly-D-
lysine/laminin-coated dishes. Approximately ~100,000 cells were seeded in 15 µl of 
medium at the center of a 3.5-cm dish and allowed to adhere at RT for 20 minutes. The 
plate was then filled with a 1:1 mixture of N2 and B27 (Neurobasal medium, 1:50 B27 
Supplement, 1% L-glutamine, 1% penicillin/ streptomycin, Invitrogen) media 
supplemented with 10 ng/ml bFGF. Cells were observed daily and medium was changed 
every 1-3 days, depending on gross assessment of cell growth and survival. In many 
cases, terminal differentiation cultures were kept at 5% O2 - a condition which seemed to 
increase cell survival, but did not appear to affect differentiation. 
 Terminal differentiation was assessed using Neuronal nuclei (NeuN), and 
Neurofilament L (NF) as neuronal markers. Cultures w re fixed in 4% PFA, post-fixed 
with 2:1 ethanol:acetic acid, treated with 0.2% Triton-X 100, and blocked in 1% fish gel. 
Primary antibodies (NeuN, NF - Millipore, Billerica, MA) were applied overnight at 4oC 
at a 1:400 or 1:200 dilution in PBS and were followed by Cy3- or Alexafluor-488 
conjugated secondary antibodies. 
 Antibodies that did not work well for immunohistochemistry were used for 
western blotting. 30 µg of protein from each sample was loaded into a gradient gel of 
either 6-12% or 6-20%, depending on the sizes of targe  proteins. Gels were run at a 
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constant current until protein markers had adequately separated and were transferred onto 
PVDF membranes which were then blocked in 10% milk in TBST. Primary antibodies 
(GFAP - Thermo Scientific, Waltham, MA; GluR1, GluR2, NR2B, NR3A - Millipore; 
NR1 - Cell Signaling; Nav1.1 - Abcam, Cambridge, MA) were applied overnight at 4oC 
at a 1:1000 dilution in 5% BSA in TBST. Exceptions i cluded NR2B and Nav1.1, which 
were used at a 1:500 dilution. AP- or HRP-conjugated s condary antibodies were applied 
for 1-2 hours at RT in 5% BSA. AP-conjugated antibodies were developed using 
NBT/BCIP solution and HRP-conjugated antibodies were developed using a Pierce ECL 
Detection Kit (Thermo Fisher Scientific, Waltham, MA). 
 
4.2.4: Electrophysiology 
 Whole-cell patch clamp recording on hES and hiPS cell-derived neurons was 
performed as in our previous studies220 using an EPC9 amplifier (HEKA Elektronik, 
Lambrecht, Germany) at 21–23°C. The external solution contained 135 mM, 5 mM KCl, 
2 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, and 10 mM glucose, pH 7.4. Internal 
solution consisted of 120 mM KCl, 2 mM MgCl2, 1 mM CaCl2, 2 mM Na2ATP, 10 mM 
EGTA, and 10 mM HEPES, pH 7.2. Recording electrodes pulled from borosilicate glass 
pipettes (Sutter Instrument, USA) had a tip resistance between 5 and 7 MΩ when filled 
with the internal solution. Series resistance was compensated by 75-85%. Linear leak and 
residual capacitance currents were subtracted on-line using a P/6 protocol. Action 
potentials were recorded under current-clamp mode using Pulse software (HEKA 
Elektronik). Data were filtered at 3 KHz and digitized at sampling rates of 20 KHz. Peak 
voltage measurements of action potentials from each condition are reported as mean ± 
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SD and were compared using ANOVA with a Tukey post-hoc test. 
 Delayed rectifier (IK) and transient outward (IA) potassium (K+) currents were 
also examined. Delayed rectifier currents were recorded in the presence of 0.5 µM 
tetrodotoxin to block sodium currents. IK was elicited from -60 to +60 mV with a 20 mV 
increment. The holding potential was -70 mV. The repo ted current amplitude was 
measured at +40 mV. IA was elicited from -60 to +40 mV with a 20 mV increm nt 
following a -110 mV hyperpolarization for 500 ms. Peak amplitudes were measured at 
+40 mV and are reported as mean ± SD. They were compared using ANOVA with a 
Tukey post-hoc test. 
 
4.2.5: Focal Ischemic Stroke Model 
 All procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) and met with NIH guidelines. Male WT C57/Bl6 mice were trained 
to remove an adhesive dot from their forepaws and then subjected to a focal ischemic 
stroke as described in previous studies.195-198 Animals were anesthetized with an 
intraperitoneal (IP) injection of 4% choral hydrate (100 mg/ml) and 2-3 branches of the 
MCA supplying the right barrel cortex were permanently ligated. In addition, the CCA 
was occluded for 7 minutes. Blood flow was measured before and during the stroke in 
order to ensure that the stroke had cut off flow to the right barrel cortex area. This focal 
ischemic stroke is centered in the barrel cortex, where it affects whisker function, but also 






FIGURE 4.2: Focal Ischemic Stroke Model 
A. Timeline for animal experiments. Transplant occurred at 7 days after stroke. 
Behavioral testing was carried out at 4 days after stroke and then at 7, 14, 21, and 28 
days after transplant. B. Sensorimotor cortex stroke model. Ligation of the branches of 
the right MCA affects the left side of the body, particularly the whisker function. Sensory 
and motor function in the left forepaw can also be aff cted. Triphenyltetrazolium chloride 
(TTC) staining after stroke reveals the affected area of the cortex.  
 
 
4.2.6: Behavioral Testing 
 Beginning 3-5 days before stroke, animals were trained in the adhesive removal 
task, in which they removed a small sticky dot from each forepaw.106 Animals were 
acclimated to the test room for at least 30 minutes and then separated into individual test 
cages, where they were allowed to acclimate for at least 5 minutes. A sticky dot was 
placed on the forepaw of the animal and it was released back into the test cage. The time 
to contact and time to removal were recorded. Both the left and right forepaws were 
tested, with at least 15 minutes between consecutive trials. Training consisted of 6-10 
trials, at the end of which animals were expected to remove the dot in less than 15 
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seconds. Each post-stroke time point consisted of 4 trials. Animals were tested at 4 days 
after stroke and then 7, 14, 21, and 28 days after transplant which occurred on day 7 after 
stroke by an observer blinded to the treatment groups. Animals with no deficiency 4 days 
after stroke were excluded from further testing. 
 Variances between groups were compared using Bartlett's test for equal variances. 
In order to compare performance, a repeated measures analysis using linear mixed 
models was performed. The fixed effects in the models included the subject's treatment 
group, time point, and the interactions between treatm nt group and time point. The post-
stroke baseline at 4 days was used to adjust for differing effects of the stroke on 
performance and measures of the unaffected side wer us d to adjust for the learning 
curve.  
 
4.2.7: Transplantation of Neural Precursors 
 Seven days after stroke surgery, hES-derived neural precursor cells were prepared 
for transplantation. Cells were treated for 1 hour with 10 µg/ml Hoechst to label cell 
nuclei. They were then rinsed with DMEM/F12 and trea ed with accutase for 30 minutes 
at RT. Cells were scraped from the plate, pipetted to break up clumps, and rinsed in 
DMEM/F12. The cell solution was then filtered through a 20 µm mesh and resuspended 
at ~50,000 cells/µl in N2 medium. Animals were lightly anesthetized with IP injections 
of 4% choral hydrate and maintained under anesthesia with isofluorane. Each animal 
received 4 1-µl injections of either cell suspension (transplantation group) or medium 
(control group) into the penumbra region. This was c rried out using a 5 µl Hamilton 
syringe (Hamilton Company, Reno, NV). Cells were inj cted very slowly by hand (10 
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minute total injection time). On the day of transplant, animals began receiving BrdU to 
label proliferating cells. Each animal received a daily IP injection of 50 mg/kg BrdU until 
the day before sacrifice. Two to three days after transplant, one animal which had 
received cells was sacrificed for TUNEL staining to check for grafted cell survival. 
Staining was carried out on 10-20 µm sections using the kit vendor instructions 
(DeadEnd™ Fluorometric TUNEL System, Promega Corporati n, Madison, WI).  
 At 28 days, animals were sacrificed and brain tissue was fresh-frozen in optimal 
cutting temperature compound (OCT, Sakura Finetek, Torrance, CA). 10 µm sections 
were cut in a cryostat with slides light-protected o preserve the Hoechst label. Each 
consecutive section on a slide was at least 100 µm distance from the previous section to 
avoid double counting cells. NeuN staining was used to i entify neurons and collagen IV 
(COL IV) was used to identify blood vessesls. COL IV is a major component of the 
basement matrix in vessels and our previous unpublished studies have shown that it 
provides blood vessel-specific staining in the brain. BrdU co-localization with NeuN was 
used as a measure of neurogenesis and co-localization with COL IV was used as a 
measure of angiogenesis.  
 For NeuN and COL IV staining, slides were fixed in 10% formalin, post-fixed 
with 2:1 ethanol:acetic acid, treated with 0.2% Triton-X 100, and blocked with 1% fish 
gelatin. For BrdU staining, slides were fixed in 10% formalin, post-fixed with 100% 
methanol, treated with 2N HCl, treated with 0.2% Triton-X 100, and blocked with 1% 
fish gelatin. All primary antibodies (Col IV, NeuN - Millipore, BrdU - AbD Serotec) 
were applied overnight at 4oC at a 1:400 dilution in PBS and were followed by Cy3-, 
Cy5-, or Alexafluor 488-conjugated antibodies.  
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 Pictures of at least three sections per animal were taken within the penumbra area 
and quantified using the ImageJ cell counter. The percentages of BrdU-positive staining 
co-localized with either NeuN or Col IV are reported as mean ± SEM and were compared 
using a Student's t-test. The control group was too small to test for normal distribution, 







4.3.1: Human ES and hiPS Cells Differentiate into Neural Precursors In Vitro 
 Human ES cells grown in feeder-free culture using mTeSR®1 medium 
maintained a normal ES cell morphology and expressed OCT4A, Nanog, and SOX2 
(Figure 4.3), indicating maintained pluripotency. Similar results were obtained with hiPS 




FIGURE 4.3: Human ES Cells Maintain Pluripotency in mTeSR®1 
Representative pictures of H1 cells stained for nanog, OCT4A, and SOX2 (red). Nuclei 
were counter-stained with DAPI. High levels of pluripotency (qualitative assessment) 







 Over 11 days of differentiation, pluripotency markers were lost and cells began to 
express neural precursor markers. We quantified the percentage of cells expressing 
nestin, PAX6, and SOX1 after 11 days of neural induction (Figure 4.4). Nestin is an 
intermediate filament protein expressed in neural precursor cells during neural 
development and repair.221 PAX6 is an important transcription factor in cortical 
development222 and is necessary for the formation of the thalamocortical tract.223 
Likewise, SOX1 is a transcription factor indicated in early neural fate specification.224 
 After 11 days of neural induction, 96 ± 3% of all cells were positive for nestin 
(Figure 4.4 A). 75 ± 7% and 64 ± 9% of cells were positive for PAX6 and SOX1 (Figure 
4.4 B and C), respectively. This indicates that a majority of cells were differentiating into 
forebrain precursors. The percentage of PAX6+ cells we obtained using dosomorphin is 
similar to that which we obtained using noggin as the BMP inhibitor (data not shown), 















FIGURE 4.4: Neural Progenitor Markers are Highly Expressed After Neural 
Induction of hES Cells 
Differentiating H1 cells were stained at day 11 of dif erentiation. A. 96 ± 3% of cells 
were positive for nestin. B. 75 ± 7% of cells were positive for PAX6. C. 64 ± 9% of cells 
were positive for SOX1. DAPI was used to counter-stain nuclei. Similar results were 















4.3.2: Neural Precursors Differentiate into Functional Neurons In Vitro 
 During terminal neuron differentiation, developing eurons formed networks with 
large numbers of NF-positive processes. Maturing neurons were identified using NeuN 
and NF staining (Figure 4.5). We were also able to identify the AMPA receptor subunit 
GluR1 and the NMDA receptor subunit NR2B in most neurons as identified by co-
localization with NeuN or NF. High power images demonstrating co-localization are 
shown in Figure 4.5. 
 In order to further characterize the neurons in culture, as well as the rest of the 
population, western blots were carried out. Western confirmed protein-level expression 
of GluR1 and NR2B. In addition, westerns determined expression of the AMPA receptor 
subunit GluR2, the NMDA receptor subunits NR1 and NR3A, and the sodium channel 
subunit Nav1.1. These subunits could all be detected as early as 14d of terminal 
differentiation and persisted through 28d. Glial fibrillary acidic protein (GFAP) was also 









FIGURE 4.5: Human ES Cell-Derived Neurons Express NeuN, NF, and Receptor 
Subunits at 28 Days of Terminal Differentiation 
H1 cells at 28 days of terminal differentiation. A. Developing Neurons formed large, 
heavily branched networks in the culture dish. B. A high power Z-stack image 
demonstrates co-localization of NeuN and NF in the cell body. Similar results for A and 
B were obtained with H9 hES cells and an hiPS cell line. C. GluR1 staining is evident on 
the cell body of a NeuN-positive neuronal cell. D. NR2B staining is evident on the cell 
body of a NF-positive neuronal cell. Scale bars are 10 µm.  
 
 
 In order to determine functionality in the developing neurons, their 
electrophysiological properties were examined over fou weeks of terminal 
differentiation. At one week, cells exhibited weak, slow responses to depolarization with 
a mean amplitude of 32.8 ± 16.6 mV. After two weeks on Matrigel-coated dishes, 
neuronal cells fired much stronger single-spike action potentials (APs), with amplitudes 
significantly increasing to 73.9 ± 5.6 mV. Further maturation significantly increased the 
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amplitude to 84.2 ± 6.3 mV and some cells began firi g epetitive trains of APs. At three 
weeks, 1/8 of the cells measured fired repetetive trains, and this proportion increased to 
about 1/3 by 4 weeks. Interestingly, poly-D-lysine/laminin-coated dishes, which are 
commonly used to support neural differentiation andgrowth, did not support maturation 
of these responses. While cells did stain positively for neuronal markers, their 
depolarization response even at 3 weeks of differentiation resembled the 1-week response 
on Matrigel-coated dishes with amplitudes that never xceeded 18.2 ± 8.4 mV. Similar 
results were obtained when this study was carried out with hiPS cells and mature, single-





FIGURE 4.6: Action Potentials From hES Cell-Derived Neurons Mature Over 4 
Weeks of Terminal Differentiation 
A. Representative AP traces. All were measured fromH1 cell-derived neurons except the 
iPS cell trace. B. APamplitude changes over 4 weeks of terminal differentiation in H1 
cell-derived neurons. Amplitudes increased over the first 3 weeks of differentiation. 
n=10, 13, 16, 29. C. Depolarization responses of H1 cell-derived neuronal cells grown 
on laminin did not change from 2-3 weeks of development, never developing mature APs. 
n=9, 13, 11, 16. *p<0.05, ***p<0.001  
 
 
 Potassium currents also changed over the time course of terminal differentiation. 
Delayed rectifier currents were significantly reduced from 206.6 ± 96.2 nA at 1 week to 
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111.2 ± 39.6 nA at 2 weeks. The trend continued at later time points, although no further 
significant changes were observed. Transient outward cu rents, on the other hand, 
significantly increased from 3.6 ± 1.4 nA at 1 week to 35.4 ± 12.8 nA at 2 weeks. At 3 
weeks, they had further increased to 80.2 ± 19.7 nA (Figure 4.7).  
 
 
FIGURE 4.7: Potassium Current Matures During Terminal Differentiation  
A. Representative traces of IK measured from H1 cell-derived neurons. B. IK significantly 
decreased from 1-2 weeks of terminal differentiation and remained lower at subsequent 
time points. n=7, 9, 11, 12. C. Representative traces of IA measured from H1 cell-derived 
neurons. D. IA significantly increased from 1-2 and 2-3 weeks of terminal differentiation. 
n=7, 9, 11, 12. **p<0.01, ***p<0.001, ##p<0.01 compared to 1 week, ###p<0.001 
compared to 1 week. 
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 The changes in APs and potassium currents described a ove are all indicative of 
maturing neurons. In addition to these signs of maturation, miniature excitatory 
postsynaptic potentials (miniEPSPs) could be measurd at all time points, with responses 
strengthening over time. These measurements indicate an excitatory phenotype in the 
cells and suggest that functional synapses were being formed.  
 
4.3.3: Neural Precursors Increase Neurogenesis and Differentiate into Neurons In Vivo 
 Four days after transplantation, the transplant region was clearly marked by 
Hoechst-labeled cells in the cortex (Figure 4.8 a). Some transplanted cells did co-localize 
with TUNEL staining (Figure 4.8 c), indicating cell death, but this was rare. At 28 days 
after transplantation, Hoechst-positive cells were still evident in the core and penumbra 
of the stroke region (Figure 4.8 d,e). Within the penumbra region, 16.0 ± 1.8% (n=4) of 
these cells stained positively for NeuN, suggesting that the transplanted cells were able to 
differentiate into neurons in vivo (Figure 4.8 f).  
 Transplantation also increased the percentage of nwborn cells differentiating into 
neurons to 9.6 ± 0.7% over 5.9 ± 0.8% in control animals. The percentage of newborn 
cells co-localizing with vessels was unchanged by cell transplantation (Figure 4.9). The 











FIGURE 4.8: Transplanted Cells Survive and Differentiate into Neurons 
(a-c) 2-3 days after transplant, Hoechst-positive cells are visible in the cortex and co-
localization with TUNEL staining (arrows) is rare. (d-e) 28 days after stroke, the infarct 
core and penumbra regions are evident in the cortex of both control and transplant 
animals. Hoechst labeling is visible in animals receiving cell transplant (e), but not in 
controls (d). (f) 16.0 ± 1.8% (n=4) of Hoechst-positive cells co-label with NeuN, 
indicating neuronal differentiation after transplant tion. 
 
 




FIGURE 4.9: Neurogenesis is Improved by Transplantation of hES Cell-Derived 
Neural Precursors, but Angiogenesis is Unaffected 
A. BrdU, NeuN, and Col IV staining in the penumbra 28d after transplant (35d after 
stroke). (a) Control, (b) Transplant. White arrows designate BrdU co-localization with 
vessels and yellow arrows designate co-localization with neurons. B. The percentage of 
BrdU+ cells co-localized with NeuN was significantly higher in transplanted animals 
than that in controls. There was no difference betwe n groups in the co-localization of 
BrdU and Col IV. Control n=4, transplant n=6. **p<0. 1. 
 
 
 Transplanted and control animals were compared in their post-treatment 
performance in the adhesive removal test, with animls in the transplant group showing 
improvement over untransplanted controls. The variances between groups in both time to 
contact and time to remove were significantly different, with much more variance in the 
performance of the control group. This suggests that recovery in those animals receiving 
cell transplant was much more consistent. A repeated m asures analysis was performed 
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on the time-to-contact and time-to-remove measured in ach group. This model was 
normalized to the post-stroke performance (4d after stroke) and accounted for the 
learning curve observed on the unaffected side. This model revealed significant 
improvement over time in the transplant group, but not in the control group. No 
significant difference over time was observed in the time taken to remove the adhesive 
dot (Figure 4.10, Table 4.1). Data listed are the estimated mean times ± standard error at 
7, 14, 21, and 28 days after transplant. These results suggest that transplant animals 
showed significant sensory recovery, while controls did not. Neither treatment group 




FIGURE 4.10: Sensory Improvement Over Time was Observed in Transplanted 
Animals 
The time animals took to first notice and contact the adhesive dot in the transplant group 
significantly improved over time (estimated slope = -0.15 ± 0.06, p=0.012). No 
significant improvement was observed in the control g up in this sensory test or in 
either group on the time to remove the adhesive dot, which was used as a test of motor 





TABLE 4.1: Transplanted Animals Significantly Impro ved in Behavior Testing 
 
  Estimated Mean (SE#) 
  7 days 14 days 21 days 28 days 
Time to 
Contact 
Transplant 7.19  (1.20) 5.06 (1.19) 4.65 (1.19) 3.75 (1.18) 
Control 5.87 (1.26) 4.21 (1.22) 4.79 (1.22) 4.11 (1.22) 
Time to 
Remove 
Transplant 10.74 (0.95) 9.30 (.0.95) 9.55 (0.95) 10.10 (0.95) 
Control 9.95 (0.97) 7.99 (0.96) 9.55 (0.97) 10.21 (0.99) 
 







Transplant -0.15 (0.06) 0.012 
Control -0.06 (0.06) 0.314 
Time to 
Remove 
Transplant -0.02 (0.05) 0.652 
Control 0.04 (0.05) 0.497 
 
Estimated mean values for transplanted and control animals in the time taken to contact 
and then to remove the adhesive dot are listed in the top table. These measures were 
normalized to post-stroke performance and the learning curve observed on the unaffected 
side. Measurements were taken 7, 14, 21, and 28 days after transplant. The bottom table 
lists the estimated slopes to test for improvement or impairment across time. The 
performance of transplant animals in the sensory measure of time to contact had a 
significantly negative slope, indicating improvement. No significant change was noted in 











 These studies describe development of a fully adherent and feeder free neural 
differentiation protocol using small molecules and common medium supplements. With 
the exception of bFGF, no recombinant factors were added to the culture medium, even 
during terminal neuron differentiation. This protocol was used to efficiently derive neural 
precursors from hES and hiPS cells and to derive electrophysiologically functional 
neurons from those precursors. Furthermore, we demonstrated that the neural precursors 
can survive transplantation into the penumbra of a f c l ischemic stroke, increase 
neurogenesis, and differentiate into neurons. 
 When using noggin as the BMP-inhibitor, Chambers et al.182 reported > 80% 
neuroepithelial induction as measured by PAX6 staining 11 days after beginning SMAD 
inhibition. We obtained about 75% of cells positive for PAX6 while using dorsomorphin, 
which is similar to both Chambers' results and those we obtained using noggin (not 
shown). Differences in the efficiency of differentiation nay be due, in part, to differences 
between cell lines.177, 225 In fact, in a recently published dorsomorphin-based protocol 
Zhou et al.186 reported 88% and 70% PAX6-positive cells from an hES and hiPS line, 
respectively, indicating cell line variability.  
 Johnson et al.189 carried out a detailed study of hES-derived neuronal maturation 
using a neural differentiation protocol involving both suspension culture for neural 
induction and a cocktail of growth factors in terminal differentiation. Repetitive action 
potentials with amplitudes of approximately 50 mV after 7 weeks of terminal 
differentiation (10 weeks total) were reported. We were able to achieve faster maturation 
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with our protocol, beginning to observe repetitive trains of APs with amplitudes above 80 
mV at only 3 weeks terminal differentiation (~5 weeks total).  
 We were further able to demonstrate that hES cell-derived neural progenitors 
survived transplantation into the penumbra region of a f cal ischemic stroke in mouse 
and differentiated into neurons in vivo. They also increased the percentage of 
proliferating cells that became neurons. Because the Hoechst label was lost during BrdU 
staining, we are unable to differentiate between endogenous response and possible early 
proliferation of the transplanted cells. With hES or hiPS cell based treatments, teratomas 
are always a concern. Long-term transplant studies have been carried out in our lab with 
hiPS cell-derived neural precursors subjected to the neural differentiation protocol we 
have described. No tumors were visible 6 months after transplant, suggesting that 
unchecked proliferation is not a problem in the transplanted cells. We are also currently 
working on protocols that will allow us to positively identify human cells in the mouse 
brain after BrdU staining. 
 Behavioral results in the transplant group revealed significant improvement in the 
time to contact measure of the adhesive removal test, while no significant improvement 
was observed in the control group. This portion of the task is a measure of sensory 
function, which we expect to be negatively impacted by our stroke model. No differences 
were observed in the time taken to remove the adhesive dot. This second portion of the 
test is a measure of motor control. While our stroke model can affect the motor cortex in 
some instances, it will not always do so. It is thus unsurprising that motor control appears 
to be unaffected by transplantation of hES cell-derived neural precursors. The results thus 
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indicate that transplantation of the neural precursors improved sensory recovery. In 
addition, the recovery pattern was more consistent in the transplant group.  
 Because our previous studies had revealed no differenc  in cell survival with 
immune suppression, we chose not to provide it in these experiments. However, we may 
have been able to achieve greater levels of neuronal differentiation in vivo if we had 
provided immunosuppressive drugs to the animals. Ideguchi et al.226 demonstrated that 
mouse ES cell-derived neurosphere graft survival was unchanged by the administration 
of cyclosporine A, but cells were less likely to develop into glia and more likely to 
become neurons when it was given. They further demonstrated that IL-6 can suppress 
neuronal differentiation in vitro. Inflammation may thus have affected the differentiation 
of our neural precursors, biasing glial differentiation over neural differentiation. 
However, we may have mitigated this effect by waiting to transplant the cells until seven 
days after stroke, when inflammation in the stroke region is no longer at a peak level.  
 Our protocol provides a relatively simple and inexp nsive alternative to many of 
the neural differentiation protocols in the literature and provides mature neurons more 
quickly and with fewer medium additives. Additional f ctors may be useful in specifying 
neuronal subtypes, but we have provided a base method w ich can be used in further 
developmental studies of neural differentiation. This differentiation protocol works with 
similar results in at least three different cell lines - H1 (male) and H9 (female) hES cells 
and the transgene-free hiPS cell line iPS-DF19-9/7T. We have also shown that cells at the 
neural precursor stage of this protocol can be transpl ted into the cortex of mice 
subjected to a focal ischemic stroke and will survive, differentiate into neurons, increase 
neurogenesis, and provide more consistent sensorimot r recovery. 
 
 82









 This thesis explores three ways in which the microenvironment of human 
embryonic stem (hES) cells, which are exquisitely snsitive to environmental signals, can 
be controlled. Precise control over cell fate will be necessary in both expansion of hES 
cell banks and differentiation of hES cells to products used in cell-based therapies. We 
investigated the effects of growth surface and O2 level on the maintenance of hES cells 
and then explored the use of small molecules in feeder-free and adherent neural 
differentiation.  
 Chapter 2 explores growth of hES cells on polydimethylsiloxane (PDMS), a 
material commonly used in the creation of micro-devic s. Cell culture and manipulation 
on the microscale are becoming increasingly popular and it will be important to 
understand how the materials used in these systems can affect cell behavior. A number of 
studies have shown that PDMS can have toxic effects on cells, and hES cells are far less 
robust than many commonly cultured cell types. By modulating the curing conditions and 
surface treatment of PDMS growth surfaces, we demonstrated that hES cells are sensitive 
to the properties of the surface, with treatments that may increase crosslinking and 
wettability improving the maintenance of healthy, undifferentiated cells. The significance 




 Chapter 3 demonstrates the use of a relatively simple, diffusion-based cell culture 
device to provide an oxygen gradient in a physiologic range of O2 to hES cells. Using this 
system, it was demonstrated that a larger number of cells were present in the lower O2
areas of the gradient than in the higher O2 areas. There was no significant difference in 
cell proliferation or cell death, suggesting that the higher cell numbers at low O2 may 
have been a combination of these two factors and cell migration. hES cells cultured in the 
gradient also better maintained pluripotency markers at lower O2 levels, a result that is 
consistent with studies examining single O2 levels in tissue culture. The significance of 
this work is that it demonstrates an easy-to-construct platform to examine the effects of 
various O2 levels on hES cells. The device was, however, limited by the tendency of cells 
grown to confluence to peel off of the substrate, pr venting the use of some 
differentiation protocols of interest. 
 In Chapter 4, a completely adherent, feeder-free neural differentiation protocol 
using small molecules and common medium supplements was explored. Neural induction 
was efficiently demonstrated using SMAD inhibition with two small molecules, 
dorsomorphin (BMP inhibitor) and SB431542 (TGF-β inhibitor). The majority of cells 
expressed multiple neural progenitor markers after induction, including those specific to 
forebrain development. No remaining pluripotent cells were observed after 
differentiation. The use of dorsomorphin in our protocol makes this process significantly 
less expensive than previous work using noggin as a BMP inhibitor. hES cell-derived 
neural precursors differentiated into mature, functioning neurons in vitro without the use 
of BDNF or GDNF, also expensive recombinant factors. Differentiation was effected 
more quickly than in previous reports in which electrophysiological maturation required a 
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significantly longer time. The differentiated neurons expressed neuronal markers and 
multiple subunits of the AMPA and NMDA receptors. Neural precursors derived using 
our protocol were further demonstrated to be feasible for use in treating focal ischemic 
stroke in mice. Transplanted cells survived in the penumbra of the stroke region and 
differentiated into neurons in vivo. They also increased neurogenesis and improved 
sensory recovery over the course of 4 weeks after treatment. The significance of this 
work is the development of a potentially translatable protocol for efficient and cost-




5.2: Discussion and Future Work 
 
5.2.1: Human ES Cells As a Source of Cell Therapies 
 There are a large number of cell sources that may be of use in treating ischemic 
stroke, but hES cell-derived neural progenitors may be particularly advantageous. In the 
proper conditions, an hES cell line can be cultured indefinitely, allowing for continuous 
production of a cell therapy product from the same source line. In contrast, most adult 
stem cells do not self-renew indefinitely. Cell therapies derived from adult stem cells will 
either require periodic re-isolation or immortalizat on. ReNeuron has now entered Phase I 
trials for the treatment of chronic ischemic stroke using a fetal neural stem cell line 
carrying a c-myc transgene activated by 4-hydroxy-tamoxifen (4-OHT).227 Cells cultured 
in the presence of 4-OHT and growth factors express high levels of telomerase and 
proliferate indefinitely, while cells without these timuli stop proliferating and 
differentiate into neural lineages in vitro and in vivo.210, 228 Methylation and silencing of 
the c-myc transgene follows withdrawal of 4-OHT and proliferation ceases. The presence 
of an oncogene transgene is still troubling due to fears of re-activation, but European 
regulators were satisfied that c-myc is silenced in the cell product. Random viral 
integration may also alter expression of other genes, potentially leading to uncontrolled 
growth of benign tumors or to malignant tumors. These concerns also apply to hiPS cell 
lines derived with integrating viral vectors. The use of hES cell-derived neural 
precursors, on the other hand, does not require gentic or epigenetic modification. 
Nonetheless, proliferation of normal CNS progenitors in the brain could also have 
devastating consequences.  
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 Pluripotent hES cell lines will also be useful in cell replacement strategies used to 
treat a wide variety of disorders. Different hES cell lines do demonstrate varying 
propensities for the differentiation of specific cell types,177, 229 and practical applications 
will probably involve many different cell lines, but proper protocols may still allow for a 
single hES cell line to be used in replacing multiple lost tissues. Adult stem cell 
populations are generally more lineage restricted. The CTX0E03 cells described in the 
preceding paragraph, for instance, will only be usef l in the context of treating 
neurological disorders. There are many neurologic disor ers potentially treatable by 
neuronal progenitors including spinal cord injury, inherited and acquired 
neurodegenerative diseases, amyotrophic lateral sclerosis, and others. However, treatment 
of non-neurologic diseases using the strategy used in obtaining CTX0E03 cells will 
require conditionally immortalizing other tissue-specific stem cell populations which may 
not be available for all cell types.  
 Some adult stem cells grown in optimal conditions can be expanded sufficiently 
to serve as cell banks for cell therapies without genetic modification. Stem Cells Inc., for 
example, grows fetal derived neural progenitors in low O2 and expands the cells for a 
variety of clinical applications now in Phase I studies, including spinal cord injury, 
inherited neurodegenerative disorders, and macular degeneration. ReNeuron is also 
developing an adult retinal stem cell, also fetal derived, that can be expanded almost 
indefinitely in low O2. 
 hiPS cells can also be used to obtain cells of any tissue type, but may carry an 
epigenetic "memory" that significantly biases them towards the source cell type. For 
example, hiPS cells can be derived from retinal pigment epithelium (RPE), but some of 
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these cell lines more readily formed RPE cells when allowed to spontaneously 
differentiate than hES cells.230 A similar trend was reported in mouse iPS cell lines 
derived from blood cells. Induced hematopoeitic differentiation was more efficient in 
these iPS cell lines than those derived from fibroblasts, which demonstrated greater 
osteogenic potential.231 In a study of hiPS cells derived from all three germ layers, 50% 
or more of the differentially expressed genes betwen hiPS and hES cell lines were also 
differentially expressed between the somatic cell type and hES cells, indicating 
incomplete reprogramming of these cells.232 The retention of memory in somatic cell 
types used for hiPS cell lines is further supported by the observation that younger (human 
umbilical vein endothelial cells) or less differentiated (fetal neural stem cells) can be 
reprogrammed using fewer exogenous factors - OCT4 and SOX2 in HUVECs233 and 
OCT4 alone in neural stem cells.23 These differences may be removed by long-term 
culture or by treatment with small molecules that remove epigenetic changes,234 but these 
studies still indicate a possible advantage of the gold standard hES to which hiPS cell 
lines are compared as sources for widespread cell therapy. A major reason for enthusiasm 
over hiPS cells was their immunologic advantage over fully allogeneic hES cells, but 
individualized development of hiPS-based therapy is considered economically unfeasible.  
 
5.2.2: Microdevices Using PDMS for Control of hES Cell Behavior  
 Regardless of the cell type used, control is a necessity in obtaining cells for 
therapeutic uses. Safety and efficacy both demand the isolation of a pure cell population 
that is not expected to exhibit uncontrolled proliferation or aberrant differentiation. 
Microdevices represent a method to achieve precise control of the cell environment and 
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examine a number of cell responses that can then be adapted to bulk culture. These 
devices can be created using a wide range of materials, but PDMS has particular 
advantages that continue to lead to its widespread use. 
 Because many biological assays rely on fluorescent d tection of biomarkers, 
autofluorescence in the growth material can be extremely detrimental. PDMS performed 
very well in a comparison of the autofluorescence of various materials in the blue, green, 
and red ranges that was normalized to thickness, with only poly(methyl methacrylate) 
(PMMA) and glass producing lower signals.235 PDMS outperformed polystyrene, a 
material commonly used in traditional cell culture dishes in this measure. Parylene C, a 
material widely considered to be biocompatible and used in a number of medical devices, 
exhibited high levels of autofluoresence in all three channels that was worsened by 
microfabrication techniques. Parylene-HT may be a btter option for fluorescent 
applications, but it was not directly compared to PDMS.  
 Gas permeability is another advantage of PDMS in ma y cell culture applications. 
Cultured cells need access to O2 for survival and medium is often buffered at the proper 
pH with CO2. Non-permeable materials such as parylene, PMMA, and polystyrene do not 
allow for transfer of gases, limiting their use in microfluidics and the creation of gas 
gradients. These materials also tend to be more brittle and less amenable to molding. All 
of the above highlights the usefulness of PDMS, and our work suggests ways that PDMS 
can be modified so that it can be used for hES cell biology.  
 PDMS does have disadvantages and they will need to be addressed to rely on the 
results of investigations using PDMS-based microdevices. The most important problem 
in cell culture applications may be the extremely hydrophobic surface presented by 
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PDMS. UV, UVO and air plasma treatment can all increase the hydrophilicity of the 
surface to varying degrees,85 but there is no consensus on the optimal treatment. There 
are no studies available on the conformation of coating proteins on PDMS surfaces in 
particular, but some guidelines may be inferred from the study of other materials, where 
various levels of wettability have been shown to change the conformations of adsorbed 
proteins. This effect is further confounded when a combination ECM matrix is used, 
altering the optimal surface conditions as compared to single proteins.138 The optimal 
wettability of the surface thus may vary, depending o  the mixture of ECM and the 
particular integrin binding sites that need to be avail ble. It is likely that the 
functionalization of PDMS surfaces will need to be optimized for each individual coating 
and cell type. Alternatively, if the necessary binding sites for a given cell type and 
outcome are known, it may be possible to design synthetic coatings that will provide 
proper attachment and growth signaling without altering the underlying PDMS.  
 It is also clear that PDMS can affect cell behavior even when it is not used as a 
cell culture surface. Increasing the ratio of the PDMS surface area to the volume of the 
medium (SA/V) caused mouse mammary fibroblasts to increase glucose consumption 
and led to cell cycle arrest in a PDMS microchannel structure with a polystyrene growth 
surface.82 It was not clear what mechanism(s) caused this cell change. Further 
investigation of PDMS interaction with cell culture r vealed that low molecular weight 
species (LMWS) leached out of the bulk polymer and could be found within cell 
membranes.83 However, it is not clear what negative effect, if any, these molecules may 
cause. Hydrophobic molecule partitioning may also be a factor in negative cell reaction to 
increasing PDMS SA/V, but this was not a factor in our study, where SA/V was low. 
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 We have provided a first look at the effects of growing hES cells on a PDMS cell 
culture surface. Our sample sizes are low, so the trends observed here will need to be 
confirmed and a greater range of cell responses will need to be observed. OCT4 is seen as 
a master promoter of pluripotency, but it is not the only transcription factor that must be 
maintained. Higher cell counts can provide evidence of proliferation, but are not a direct 
measure like BrdU incorporation. The adhesion molecules involved in attachment and 
growth on PDMS will need to be elucidated to optimize the functionalization of the 
surface. This can be aided by surface studies examining the contact angle and surface 
chemistry of the PDMS, but may be better answered with antibodies to particular ECM 
binding sites or the use of integrin blocking antibodies that may further impair cell 
attachment and growth. The control provided by PDMS-based microdevices can be a 
useful tool in optimizing growth conditions for the maintenance of pluripotent stem cells. 
 While it is unlikely that PDMS will ever be used as  long-term growth surface 
for hES cells, these examinations provide some insight into the development of an 
optimal substrate to maintain pluripotent cells destin d to be used in cell therapies. Such 
a material will need to be xeno-free, which means that Matrigel coating will have to be 
replaced, and non-toxic. This can likely be achieved with synthetics, which can provide 
repeatable, defined substrates that can be manufactured in large quantities. This surface 
will need to present proper integrin binding sites to allow for cell attachment and desired 
cell responses. It may even be optimized for particular cell lines, as individual cell lines 
may vary in the particular integrins required for attachment, proliferation, and 
differentiation.53 Ideally, a growth surface used for adherent hES cell maintenance will be 
gas permeable and porous, to allow for ready distribution of gases and nutrients in 
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scalable multi-layer cultures. For the short term, microdevices will be most useful in 
studying cell behavior rather than in development of clinical-scale expansion and 
differentiation. Many groups are working on suspensio  cultures of hES cells, so that the 
protocols used for cell manufacture are increasingly different from those used to study 
cells in microdevices.  
 
5.2.3: Controlling the O2 Tension in hES Cell Culture 
 In addition to determining the optimal growth substrate for hES cells, it will be 
important to determine the optimal O2 conditions for long-term culture. Traditional cell 
culture does not provide control of O2 tension, but it is becoming increasingly recognized 
as an important consideration, particularly in stem cell biology. The accumulation of 
oxidative damage from reactive oxygen species (ROS) produced in cells has long been 
recognized as a mechanism in aging236 and more recent studies have identified it as a 
causative factor in early senescence of hematopoietic st m cells (HSCs) during 
expansion.237 Increased O2 in culture conditions can increase the availability of ROS and 
thus the degree of DNA damage the cells accrue. This may contribute to the karyotypic 
changes observed in many hES cell lines after long-term culture.  
 ROS also play a normal role in modulation of signaling pathways, including those 
involved in differentiation of endoderm. In particular, ROS signaling has been indicated 
in cardiogenic differentiation of mES cells, through mechanisms that may be regulated by 
cyclic stretch238 or mitochondrial metabolism.239 Mitochondrial production of ROS may 
also induce differentiation in hES cells, as supported by a report that inhibition of 
mitochondrial ROS production with antimycin A increases nanog and decreases markers 
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of early differentiation in hES cells grown at 20% O2.
240 Similarly, small molecule 
inhibition of the eicosanoid signaling pathway, which produces ROS as a product of 
multiple oxidation reactions, in mES cultures promoted pluripotency, even in 
differentiation conditions.241 
 Maintenance of healthy cells is not, however, merely a matter of reducing ROS to 
minimal levels. Treatment of hES cultures with high, but non-toxic concentrations of 
antioxidants including catalase actually increased levels of DNA damage over those 
found in cultures with more moderate concentrations.242 In cardiosphere-derived cells, 
culture in 5% O2 significantly reduced the measured levels of DNA damage, but high 
levels of antioxidants significantly increased them. Excessive ROS suppression was 
found to downregulate DNA repair mechanisms, while culture in low O2 provided less 
suppression and DNA repair mechanisms remained intact. There is thus support for an 
oxidative optimum in cell culture, and this optimum is likely to be cell-type specific. The 
ideal anti-oxidant treatments have been difficult to identify, in part, because measurement 
of oxidants is technically difficult. 
 Lowered O2 also modulates hypoxia inducible factors (HIF) andthe pathways 
they regulate. Of particular note in hES cell regulation are HIF-2α regulation of OCT4 
and HIF-1α regulation of the wnt/β-catenin pathway. While HIF-1α does not seem to 
interact directly with nanog, OCT4, or SOX2, collectively seen as the master regulatory 
triad in maintaining pluripotency, HIF-2α directly upregulates OCT4166 and is likely a 
involved in low O2-mediated cell maintenance. HIF-1α may also contribute to this 
process in a less direct manner by upregulating the wnt/β-catenin pathway and 
consequently, lymphoid enhancer-binding factor-1 (LEF-1).243 LEF-1 interacts with 
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nanog and upregulates OCT4 promoter activity.244 This pathway may actually be lost as 
cells differentiate, as low O2 and the β-catenin pathway no longer mediate LEF-1 after 
neuronal differentiation.243 Thus, stabilization of HIF proteins in low O2 conditions can 
contribute to maintained pluripotency and survival through multiple pathways. 
 In the search for ever-improving cell culture conditions, it is advantageous to use 
high-throughput methods allowing simultaneous examin tion of multiple conditions. A 
number of devices have been designed to provide defined O2 gradients in cell culture, but 
none have achieved widespread use in biological applic tions. This may be partly due to 
the complex fabrication techniques and equipment requi d to create them.  
 We used a relatively simple diffusion-based design that does not require high-tech 
fabrication for use and thus may be seen as more accessible to those in biology 
laboratories. This device can be placed in a standard cell culture incubator and uses the 
same gas mixture employed in most low O2 culture. We validated the utility of this 
device by examining the effect of a range of physiologically relevant O2 tension on the 
maintenance of pluripotent hES cells which have not, to our knowledge, previously been 
grown in a device designed to present an O2 gradient. Using this device, we confirmed 
the results of other investigations showing that lowered O2 tension improves the 
maintenance of pluripotent markers. We were able to further narrow the optimal range of 
O2 tension in hES cell culture to below 5%, providing guidance for further optimization 
studies.  
 While there is no precise control over the shape of the gradient presented by this 
device, it could be combined with more traditional methods for lowering O2 to narrow the 
range of O2 tension encountered by cells. The ambient levels of O2 surrounding the 
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device determine the maximum tension encountered within the gradient. Thus, lowering 
this level by placing the device in a modular incubator or in a standard incubator with a 
gas mixture below 20% O2 will consequently narrow the range of O2 available in the 
gradient created. The device could be used in this manner to further narrow the range of 
O2 tension that may be considered optimal for a desired cell response. 
 Oppegard et al.245 provided another device that could be used for screening 
various O2 levels. This device is an insert for 6-, 24-, or 96-well plates that can be used to 
vary the O2 level within the culture well in a time-dependent manner. This device uses 
gas flow through a microfluidic chamber that is affixed over the growth surface in a 
standard cell culture plate. Gas diffuses from the microfluidic chamber into the culture 
medium across a PDMS membrane. Precise control of the O2 tension can be achieved by 
varying the concentration of O2 in the gas, flow rate, and the height of the culture 
chamber. Oppegard demonstrated both precise control of a single O2 level within the well 
or provided zones of high and low O2 with more complex designs. This device does 
employ fabrication techniques, but it could be used to provide more control over the O2 
conditions and larger areas of particular O2 tensions for analysis than our device and thus 
may be more useful after an initial screen like the on  we provided. 
 Oxygen does not exist at single discrete levels in vivo, instead being found as a 
gradient in all tissue types. It can thus be of interest to grow cells in a gradient with a 
more directly physiologically applicable shape and O2 tension span. Unfortunately, the 
non-linear shape and lack of precise control of the gradient in this device make it more 
suitable as a screen for various O2 tensions than as a device that can accurately mimic in 
vivo O2 gradients. Allen and Bhatia
162 demonstrated the use of a flat-plate fluid flow 
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reactor to provide a physiologically relevant gradient to rat hepatocytes. Culture medium 
was oxygenated before it was introduced to the device and a gradient was formed through 
convection and cell consumption. This device introduces shear stress in addition to the O2 
gradient, but is not inappropriate in a cell type that would be exposed to fluid flow in
vivo. When grown in this bioreactor, rat hepatocytes took n various phenotypes across 
the span of the gradient that mimicked liver zonation in vivo, making this a very useful 
model for liver studies. Mehta et al. used a similar strategy to create an O2 gradient in a 
microfluidics device and demonstrated that the slope f the gradient could be 
significantly altered as a function of the flow rate and cell density.170 These parameters 
could thus be used to provide a specified gradient in culture. 
 As with our investigation of hES growth on PDMS, the ultimate goal is to work 
towards precise control of cell fate in culture. The optimal O2 concentration for the 
maintenance of pluripotent hES cells will be determined by culture conditions that 
maintain nanog, OCT4, and SOX2 at appropriate levels to maintain pluripotency and that 
maintain low levels of differentiation markers. These conditions may have to be adjusted 
as colonies expand. Oxygen levels need to be high enough for cells to maintain proper 
metabolic pathways, including the generation of lowevels of ROS for signaling and 
regulation of DNA repair mechanisms, while being low enough to prevent accumulation 
of ROS-mediated DNA damage and to activate HIF pathw ys modulating pluripotency. 
Once a consensus is reached as to the optimal O2 tension, cell culture should be carried 
out in conditions that do not transiently expose cells to higher, damaging O2 tensions. 
Culture platforms that allow for continuous applicat on of lowered O2 to cells are too 
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bulky and expensive for screening, but will likely be well worth it for long-term culture 
of cells at an optimized O2 tension. 
 
5.2.4: Differentiation of hES Cell-Derived Neural Precursors for the Treatment of 
Ischemic Stroke 
 
 Better control and maintenance of healthy, undifferentiated hES cells will be 
invaluable to their use in deriving products for cell therapy. The next step is then to 
achieve efficient and scaleable directed differentiation of a desired cell type. We 
examined neural differentiation in feeder-free, adherent cultures that can allow for greater 
control than traditional neurosphere or co-culture models.  
 Chambers et al.182 achieved efficient differentiation of PAX6-positive neural 
progenitors in an 11-day protocol using 500 ng/ml recombinant noggin and 10 µM 
SB431542 to achieve SMAD inhibition. Chambers found that both factors were 
necessary to achieve efficient differentiation, although each factor alone could drive some 
neural differentiation. In contrast, Zhou et al.186 reported efficient monolayer 
differentiation using 1 µM dorsomorphin as the only inhibitor, with no increas  in 
differentiation observed when combined with SB431542. The effect was maximal by day 
seven. Dorsomorphin is generally seen as a BMP inhibitor with similar function to 
noggin, but Zhou demonstrated that it affected activin and TGF-β signaling as well, 
which may explain the lack of additive effect when SB431542 is used. Cells were also 
seeded at a higher initial density and grown to conflue ce in mTeSR®1 as opposed to 
MEF-CM, which may have had an affect on differentiation. Combination treatments of 
dorsomorphin and SB431542 have also been studied in the context of improving 
differentiation in neurosphere and feeder-layer based protocols.175, 246 
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 Both of these studies provided evidence of efficient generation of neural 
precursors and the derivation of neurons in vitro. Zhou demonstrated the ability of these 
neural precursors to form TUJ-1 and Nurr1 positive neurons after two weeks in a medium 
containing N2 supplement and a number of recombinant growth factors, including 
BDNF, GDNF, sonic hedgehog (shh), and fibroblast growth factor 8 (FGF8). Chambers 
added dopaminergic or motor neuron patterning factors in addition to BDNF and GDNF 
and demonstrated positive staining for Tuj-1 and TH for dopaminergic neurons or ISL1 
and HB9 for motor neurons. Electrophysiological properties of these neurons were not 
reported. 
 We used a differentiation protocol very similar to that reported by Chambers,182 
but greatly reduced the cost by using 3 µM dorsomorphin in place of noggin. In light of 
the report that dorsomorphin alone can affect neural differentiation,186 we may have been 
able to remove the SB431542, but this was not studied. Using our less expensive 
combination of factors, we report very similar levels of neural induction as those obtained 
by both Chambers and Zhou. We obtained NeuN- and NF-positive neuronal cells within 
1 week of passaging and examined elecrophysiological development over the course of 4 
weeks.  
 Johnson et. al.105 carried out a study of functional development in hES-derived 
neurons over the course of 7 weeks of terminal differentiation (10 weeks from the onset 
of differentiation in hES cells). Using suspension culture and neural rosette isolation in 
N2 medium supplemented with bFGF, PAX6+/Sox1+ progenitors were obtained within 2 
weeks, similar to our time course. These were again cultured in suspension for 1 week 
before plating for terminal differentiation in a medium containing BDNF and GDNF, 
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among other factors. Electrophysiological properties w re examined at 1, 3, 4, and 7 
weeks after plating for terminal differentiation (4, 6, 7, and 10 weeks total). High 
amplitude, single-spike action potentials (APs) were first reported at 4 weeks of terminal 
differentiation, with repetitive trains observed in some cells at 7 weeks.  
 In contrast, we obtained high amplitude, single-spike APs 2 weeks after plating in 
a neuronal differentiation medium containing N2 and B27 supplements with bFGF as the 
only growth factor added (4 weeks total). We began to obtain repetitive trains at 3 weeks 
terminal differentiation (5 weeks total) and the proportion of cells firing them increased 
with another week of culture. Johnson also examined transient inward and delayed 
rectifier potassium currents, with similar trends to those we reported. As with APs, 
however, maturation in their cells required a longer period in culture. We have therefore 
greatly reduced the time and cost associated with obtaining electrophysiologically active 
neurons in vitro.  
 While we derived electrophysiologically active neurons with only bFGF as a 
recombinant growth factor, it is possible that furthe  patterning factors will be necessary 
to derive specific neuronal subtypes. This protocol may thus represent a basic protocol 
for neuronal differentiation that can then be furthe  supplemented for desired outcomes. 
Further study will be necessary to determine what sub ypes are currently obtained, and 
changes can then be made to alter that pattern. Patterning factors are usually recombinant 
growth factors, but small molecules may allow for decreased cost in this arena as well. 
As an example, purmorphamine is a sonic hedgehog (shh) agonist that has been used in 
the derivation of dopaminergic neurons.247 This control will be important in the 
development of cell replacement therapies because it will be important to demonstrate in 
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vitro that precursor cells can develop into the proper type of neuron they are meant to 
replace when integrated into the tissue. To this same end, it will be important to further 
identify the non-neuronal cells in culture with an emphasis on demonstrating that the cell 
types derived become post-mitotic upon differentiation and do not form any inappropriate 
cell types. 
 In our transplant model, we demonstrate the ability of small molecule-derived 
neural precursor cells to survive up to 28 days in the mouse cortex after ischemic stroke, 
differentiate into neurons, and improve both formation of new neurons and sensory 
function as measured by a behavioral test. The mechanism in this recovery, however, is 
not clear. It is possible that the cells are forming functional neurons and directly 
improving function in the sensory cortex region butthey may also become glial cells that 
provide support to the endogenous neurons. The mechanism of action may not be cell 
replacement at all, as positive effects may be gained simply by trophic support signals 
from the transplanted cells. We intended to address thi  possibility by examining 
endogenous neurogenesis and angiogenesis. However, angiogenesis was not altered by 
transplantation and we have thus far been unable positively identify new neurons as 
endogenous cells. Furthermore, trophic factors could change the vascular tone, locally 
providing more blood supply without generation of new blood vessels, and verification of 
this mechanism is not possible in our set-up.  
In a similar stroke study in our laboratory using hiPS cells, animals were followed 
up to 6 months after transplantation. At that point, no Hoechst-positive cells could be 
found. This may indicate a loss of the graft over time, but it also may represent the 
gradual loss of the Hoechst dye. We are currently working on immunohistochemistry 
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protocols that will allow us to more positively identify human cells in rodent brain to 
better identify endogenous neurogenesis and examine long-term graft survival. 
 Among current human CNS stem cell therapies entering the clinic, there are 
examples of both temporary and long-term engraftmen. In ReNeuron's Phase I trial using 
fetal -derived stem cells for chronic stroke, as an example, cells are not expected to 
engraft long-term. In animal models, no cells were detected six months after transplant. 
In contrast, long-term engraftment is expected in trials run by StemCells Inc. using a 
similar cell line to treat Batten's disease and chronic spinal cord injury. They have already 
demonstrated transplanted cell persistence at nearly a year after transplant.227 
 Another important factor to consider in transplantation is that of immune 
suppression. The brain has traditionally been thougt of as an immune-privileged site in 
which cells could be transplanted with little fear of rejection. The blood-brain barrier 
(BBB) typically blocks the influx of leukocytes that would be expected to mediate a 
rejection response. However, the BBB is disrupted after stroke and after surgical 
manipulation, allowing for an early influx of leukocytes.208, 248, 249 Furthermore, 
inflammatory processes may still be able to recruit leukocytes after BBB function is 
repaired.250 Microglia within the brain also mediate inflammatory processes and may 
protect neurons against invading leukocytes.249  
 Immune suppression may be desirable in a cell transpl t therapy to avoid any 
activation of a rejection response, which may further arm the surrounding tissue in 
addition to blocking the beneficial effects gained from the cell graft. However, there is 
evidence that the immune system is already naturally suppressed after stroke, leading to 
an increased risk of infection.208 Further immune suppression in treatment could thusbe 
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detrimental, especially if cell transplantation is carried out after the acute phase, when 
recruitment of leukocytes to the site would be more difficult. A different approach may 
be found in co-transplantation of anti-inflammatory mesenchymal stem cells (MSCs). In 
a mouse model of multiple sclerosis (MS), co-transplantation of syngeneic MSCs with 
allogenic mES-derived oligodendrocyte precursors (OPC) resulted in better survival of 
the OPCs and greater levels of remyelination than when OPCs were transplanted alone.251 
It is possible that co-transplantation of MSCs with hES-derived neural precursors would 
likewise improve graft survival and positive outcomes. 
 We chose not to administer immune suppression in our experiments, because no 
difference in the survival of transplanted cells was observed when injections of 
cyclosporine A were given in previous studies carried out in our lab. However, cell graft 
survival may not be the only important consideration. Ideguchi et al.226 transplanted 
allogenic mES-derived neural precursors into an unij red mouse brain and found that, 
while graft size was unaffected by the administration of cyclosporine A, differentiation of 
the cells was altered. In animals receiving immune suppression, a significantly greater 
percentage of grafted cells expressed NeuN, indicating neuronal differentiation. This 
same trend was observed in tyrosine hydroxylase staining, indicating a greater proportion 
of dopaminergic neurons when immune suppression was administered. This effect was 
achieved in vitro with the addition of interleukin factor 6 (IL-6) to neuron-inducing 
culture conditions. Neuronal markers were suppressed, while astroglial markers were 
upregulated. Based on these results, it is possible that immune suppression may be 
necessary to achieve significant neuronal differentiation and integration from a cell graft 
treating stroke, despite the relative immune privilege of the brain. 
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 Our use of transplanted hES cell-derived neural precursors in a murine model of 
focal ischemic stroke provides clear evidence that t e small molecule approach to 
differentiation can provide cells that improve outcomes in a pathological setting. 
However, there are many factors that would need to be addressed before a similar 
protocol could be used in the clinic. First among these are the use of animal products, 
including Matrigel and some of the components of N2, that will need to be replaced to 
prevent xenogenic contamination in a cell products.  
 The effects of the small molecules will also have to be better defined to ensure 
consistency and the lack of unintended cellular changes. As with any treatment, small 
molecules can have off-target effects. In fact, dorsomorphin has recently been shown to 
inhibit vascular endothelial growth factor (VEGF) signaling in addition to the BMP 
pathway.252 It thus may be beneficial to investigate the use of a more targeted BMP 
inhibitor such as DMH1 in this application. It will a so be important to establish that 
signal inhibition does not continue after the small molecule stimulus is removed. 
 Before any cell treatment reaches the clinic, it is mportant to establish standard 
operating procedures to control cell fate and scale up cultures, as well as standard 
operating procedures for clinical interventions to yield positive outcomes in the disease 
model. We have provided a first examination of the hES-cell growth on PDMS, moving 
towards the use of microdevices in establishing precise control over cell fate. We 
narrowed the optimal range of lowered O2 for the maintenance of these cells, moving 
towards improved cell culture conditions that may improve the maintenance of 
pluripotency and avoid accumulation of genetic damage. We further provided a neural 
differentiation protocol that greatly reduces the cost and time scale needed to obtain 
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neurons from hES cells in vitro, facilitating future scale-up of both the derivation of 
neural precursors and the neuronal differentiation that will be needed to validate their 
function. Finally, we demonstrated the ability of hES cell-derived neural precursors 
derived using this protocol to engraft, differentiate, and improve outcomes in a murine 









FIGURE A.1: CAD Drawing of the Acrylic Frame For th e O2 Gradient Device 
This frame is the only portion of the oxygen gradient device that needed to be machined 
outside the lab. The acrylic is approximately 5/32" thick. The corners can be slightly 
rounded. This is the structure that held the polystyrene growth surface in the device and 
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